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Executive Summary 
On February 28 through March 2, 1999, the Centers for Disease Control and Prevention (CDC) 
and other agencies of the Department of Health and Human Services (HHS) brought together 
scientists, clinicians, veterans, veterans’ service organizations, Congressional staff, and other 
interested parties to discuss and make recommendations regarding the direction of future research 
on undiagnosed illnesses among Gulf War veterans and their links with multiple chemical and 
environmental exposures. The format for the conference included plenary sessions, concurrent 
workgroups, and a veterans’ forum.  The plenary sessions were meant to provide background 
information and to stimulate dialog on research questions. The plenary sessions included an 
overview of research findings regarding the health impact of the Gulf War, a panel discussion of 
the experience of Gulf War veterans, a series of presentations on the possible health outcomes of 
low-level chemical exposures focusing on nervous system, immune system, and pulmonary system 
outcomes, a series of panel discussions on research and clinical findings regarding multiple 
chemical sensitivity among Gulf War veterans and civilian populations, a series of presentations 
on possible mechanisms of action of chemical exposures, and a panel discussion on 
methodological considerations in studying the health impact of chemical exposures during the 
Gulf War. 
The concurrent workgroups were asked to develop research recommendations in four areas: 
pathophysiology, etiology, and mechanisms of action; assessment and diagnosis of illnesses; 
treatment; and prevention of illnesses in future deployments. Each workgroup was asked to 
develop research recommendations that addressed specific issues. For the pathophysiology 
workgroup, these issues included synergistic and subclinical effects of chemicals, genetic 
susceptibility, biomarkers of susceptibility and exposure, and appropriate study methods. The 
assessment and diagnosis workgroup was asked to focus on case definition, overlap of conditions, 
the role of chronic multi-system conditions, biomarkers of illness, optimal methods for assessment 
and diagnosis, and validation of assessment approaches. The treatment workgroup was asked to 
focus on appropriate treatment paradigms, rehabilitation approaches, health care opportunities, 
education of physicians, and appropriate study methods. The prevention workgroup was asked to 
focus on health education and risk communication, approaches to environmental assessment, 
biomonitoring, and health preparedness. The workgroups were free to use whatever approach 
they found useful for developing research recommendations. In some cases there was 
considerable disagreement among workgroup members on the direction of the recommendations. 
Thus, the final recommendations of the workgroups were not necessarily endorsed by all 
workgroup members. 
This report summarizes the outcome of each of the four workgroup sessions. Chapters 2 - 5 
present the recommendations as developed by the workgroups. Although the workgroups were 
asked to focus on research recommendations, some recommendations reflect clinical care, 
administrative, or policy issues. No attempt was made to filter non-research recommendations 
1
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from this report. Chapter 6 provides a discussion of the workgroup deliberations and attempts to 
place the recommendations in the context of current Gulf War research activities. 
The recommendations developed at this conference represent the deliberations of the workgroup 
participants and do not necessarily imply endorsement by the veteran or scientific community as a 
whole or by the federal government. While some of the recommendations could be implemented 
in the short-term, many of the recommendations reflect long-term goals requiring significant 
restructuring of current systems and are unlikely to be easily implemented, especially in the time 
frame requested by Gulf War veterans. Some of the recommendations may not be feasible, given 
current federal regulations. Other recommendations reflect initiatives that have already been 
instituted by federal agencies responsible for the care of veterans. 
Pathophysiology Workgroup Recommendations 
The pathophysiology workgroup made recommendations for a variety of human and animal 
studies. Recommendations for human studies include analysis of various deployment cohorts and 
other coalition partners, studies of chemical exposures in non-Gulf War settings (such as 
examination of the health effects of destruction of chemical warfare agents and pesticide 
exposures), susceptibility studies, and examination of chemically sensitive patients. 
Recommended animal research includes studies of synergistic, sub-clinical, low-level, and multi-
generational exposures; studies to develop animal models for chemical sensitivity and other 
conditions; studies examining patterns of gene expression and delayed expression of effects of 
environmental exposures; and studies of sex differences in effects of chemical exposures. The 
pathophysiology workgroup also made recommendations regarding use of new methodologies 
and special needs. These include recommendations regarding biomarker research, new analytic 
technologies, use of environmental control units, establishment of a Gulf War research library, and 
need for research oversight. 
Pathophysiology Workgroup Recommendations 
I. Human Studies 
1. Analysis of deployment cohorts 
2. Analysis of exposed Gulf War veteran populations from other countries 
3. Studies of potential health effects of destruction of chemical warfare agents in the U.S. 
4. Studies of potential health effects of pesticide exposures 
5. Susceptibility studies 
6. Studies of chemical sensitivity 
2
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II. Animal Studies 
1. Studies of synergistic effects of exposures 
2. Studies of subclinical effects of exposures 
3. Studies of low-level, chronic exposures 
4. Studies of multi-generational exposures 
5. Studies to develop animal models for chemical sensitivity and other conditions 
6. Studies to examine patterns of gene expression 
7. Studies to evaluate delayed expression of effects of environmental insults 
8. Studies of sex differences in effects of chemical exposures 
III. New Methodologies 
1. Quantitative Structure-activity Relationship (QSAR) modeling 
2. Development of biomarkers of exposure, susceptibility, and effect 
3. Use of anti-sense DNA technologies 
4. Use of multifactorial statistical models 
5. Use of transgenics and knockouts for studies of genetic susceptibility 
6. Use of alternatives to animal systems 
7. Use of imaging techniques 
IV. Special Needs 
1. Centralized Gulf War research library and data repository 
2. Controlled-environmental medical unit 
V. Establishment of a research oversight mechanism 
Assessment and Diagnosis Workgroup Recommendations 
The assessment and diagnosis workgroup developed research recommendations covering a wide 
range of issues including case definition, study of chronic multi-system conditions among Gulf 
War veterans (such as chronic fatigue syndrom, multiple chemical sensitivity, and fibromyalgia), 
and studies to examine the overlap of these conditions. The workgroup also made 
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Assessment and Diagnosis Workgroup Recommendations 
I. Case Definition 
1. Establish methods for comparing case definitions for chronic multi-system conditions 
2. Specify diagnostic criteria used in research studies 
3. Subtyping of Gulf War related illnesses should be based on available data 
II. Chronic Multi-System Disorders 
1. Conduct research on the prevalence and overlap of chronic multi-system disorders 
2. Conduct studies to assess multi-system disorders among Gulf War veterans 
3. Use novel techniques to study chronic multi-system disorders 
4. Examine barriers to diagnosis of chronic multi-system disorders 
III. Well-Defined Disorders 
1. Use well-established diagnostic coding systems 
2. Document coexisting conditions 
IV. Overlap of Conditions 
1. Define exclusionary diagnostic criteria 
2. Specify methods for assessing overlap in symptoms and diagnoses 
3. Examine the role of treatment seeking 
4. Examine the role of pre-existing disorders 
5. Examine the role of gender status 
V. Biomarkers 
1. Develop biomarkers for past exposures 
2. Use existing biomarkers on combinations of chronic multi-system disorders 
VI. Assessment and Diagnosis 
1. Assessment techniques should reflect specific hypotheses 
2. Conduct behavioral or physiological challenge studies 
3. Develop new laboratory tests of chemical effects 
4. Use combinations of assessment and diagnostic techniques 
4
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5. Use a comprehensive assessment approach 
6. Consider using non-routine assessment approaches 
7. Use assessment instruments that have established normative and validity data 
8. Conduct research to assess longitudinal health changes in normal populations 
9. Conduct studies that include careful assessment of confounders and effect modifiers 
10. Conduct protocol driven autopsy studies following the death of a Gulf War veteran 
VII. Conduct validation studies 
VIII. Declassify and disseminate all relevant scientific field investigations and 
clinical studies 
Treatment Workgroup Recommendations
 The recommendations of the treatment workgroup emphasized the need for increasing current 
treatment options for Gulf War veterans, using research methods to assess treatment efficacy, and 
assessing veteran satisfaction with treatment. Recommendations were also made regarding the 
development of therapeutic options by controlled clinical trials, with evidence-based trials having 
the highest priority. In addition, the development of new strategies for physician education and 
the assessment of the effectiveness of the education were emphasized. The treatment workgroup 
made specific recommendations in four areas: pharmacologic therapy, non-pharmacologic 
approaches, treatment regimens based on chemical intolerance, and “macro” issues, such as the 
patient-physician relationship, the interrelation of the individual to the organization, veterans’ 
satisfaction with care, and education of physicians. 
Treatment Workgroup Recommendations 
I. Pharmacologic Therapy 
1. Examine the efficacy of pharmacologic therapy to treat specific symptoms 
2. Conduct studies to examine the role of neurally-mediated cardiovascular changes 
3. Conduct trials to examine the role of sub-clinical hypothyroidism and hypoadrenalism. 
4. Examine the benefits of nutritional supplements 
II. Non-pharmacologic Therapies 
1. Conduct pre-care needs assessment 
2. Develop pre-care guidance on self-care strategies 
5
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3. Use a primary care and collaborative primary care approach to treatment 
4. Provide intensive specialized care for chronic symptoms of unclear etiology 
5. Evaluate novel, new, or promising non-pharmacological treatment modalities 
6. Develop a coordinated quality improvement program 
III. Treatment Regimens Based on Chemical Intolerance 
1. Conduct treatment trial to examine efficacy of detoxification approaches 
2. Examine efficacy of a physician-directed, home-based chemical intolerance assessment
 and avoidance approach 
3. Examine efficacy of a chemical detoxification, trial and error testing, and avoidance
 approach 
4. Conduct a double-blinded placebo-controlled trial of drug elimination 
5. If indicated by above studies, construct environmental control unit to diagnose and
 treat Gulf War veterans who have chemical intolerances 
IV. Macro Treatment Issues 
1. Establish a Logistics and Communication Network Center 
2. Conduct focus groups to assess Gulf War veterans’ health care needs and health
 care provider concerns 
3. Develop protocols focusing on communication and education issues 
4. Develop mechanisms to update primary care practitioners 
5. Monitor the availability of effective treatments for compassionate use 
6. Develop mechanisms to monitor quality of care 
7. Create a virtual library of high quality patient information 
8. Develop methods to increase patients’ access to their medical records 
9. Conduct research to enhance treatment of multi-system diseases in primary care 
Prevention Workgroup Recommendations 
The prevention workgroup focused on developing recommendations to reduce or eliminate health 
effects associated with future deployments. The workgroup relied on the occupational and public 
health concept of "hierarchy of control strategies." This concept emphasizes the importance of 
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developing an ordered hierarchy of prevention and intervention strategies. Specific 
recommendations were made regarding interventions to reduce or eliminate environmental 
hazards, including use of engineering controls, examination of work practices, and modification of 
personal protective equipment. Recommendations were also made for improving health education 
and risk communication efforts, and for surveillance and biomonitoring initiatives. 
Prevention Workgroup Recommendations 
I. Substitution Approaches 
1. Identify less toxic substances and their interactive effects 
2. Restrict the need for use of multiple pesticides 
3. Optimize vaccine potency, formulation, dose, and duration 
II. Engineering Controls 
1. Evaluate the current design and operation of equipment and material to reduce hazards 
2. Design containment for transport of contaminated material 
III. Administrative Controls - Health Education 
1. Identify and segment key audiences 
2. Determine appropriate instructional strategies 
3. Identify barriers to understanding the importance and impact of health education
 messages on readiness 
IV. Administrative Controls - Risk Communication 
1. Develop and test message content and channels 
2. Identify multiple audiences and information sources 
3. Assess effective communication of scientific uncertainty and technical information 
4. Assess comprehension, utility, and value of risk information 
5. Identify methods to communicate comparative risk issues 
V. Administrative Controls - Environmental Surveillance 
1. Develop enhanced instrumentation for nuclear, biological, chemical, and
 environmental exposure assessment 
2. Establish exposure limits that take into account multiple operating environments 
3. Characterize the environment of deployment 
7
 
    Research Planning Conference Report 
VI. Administrative Controls - Medical Surveillance 
1. Develop a data gathering tool that spans the life of the service member 
2. Validate self-reported environmental exposures 
3. Develop an effective prospective surveillance system for multiple endpoints 
4. Develop methods for surveillance of low level exposures 
5. Develop methods for archiving biological specimens 
VII. Work Practices 
1. Evaluate existing health hazard protocols 
2. Explore the impact of varied work organization structures on negative health outcomes 
3. Develop mechanisms to insure implementation of management controls 
VIII. Personal Protective Equipment (PPE) 
1. Design protective clothing that is durable, viable, and ergonomically flexible 
2. Develop and validate data/standards for PPE compliance 
Summary 
HHS convened this conference in order to further the dialogue between government officials, 
scientists, and veterans on issues of upmost concern to the veterans of the Gulf War. Despite 
considerable government and non-government sponsored research to address the health impact of 
the Gulf War, we have yet to find the scientific basis for these veterans’ unexplained illnesses. 
This conference highlighted the importance of including veterans in the process of planning and 
implementing research. Veterans and scientists alike expressed that they found the process useful 
and that future similar efforts should be encouraged. 
The recommendations developed at this conference represent the deliberations of the workgroup 
participants and do not necessarily imply endorsement by the veteran or scientific community as a 
whole or by the federal government. The purpose of this report is to document the conference 
workgroup deliberations and to form the basis for further discussions regarding the direction of 
research into illnesses among Gulf War veterans. 
It is anticipated that this report will be of interest to a broad range of individuals and organizations 
and may encourage new research collaborations and exchanges. HHS has coordinated its Gulf 
War related research activities with those of the two principally responsible agencies, the 
8
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Department of Defense and the Department of Veterans Affairs through the Research Working 
Group (RWG) of the Persian Gulf Veterans Coordinating Board. It is through the RWG that the 
federal research agenda is developed and coordinated. Recommendations for new research will 
need to be considered in light of the existing research portfolio of the RWG. 
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Chapter 1 
Introduction 
Since the end of hostilities, portions of the U.S. armed forces deployed to the theater of 
operations during Operations Desert Shield and Desert Storm have reported illnesses, some of 
which do not fall under the classic definitions of known diseases. The illnesses encountered by 
these individuals present with a variety of symptoms including fatigue, cognitive dysfunction, skin 
rash, sleep disturbances, musculoskeletal problems, diarrhea, and depression. For many Gulf War 
veterans, these symptoms have presented without objective signs of disease or laboratory findings. 
The cause of the illnesses seen in Gulf War veterans has been the subject of much speculation, 
debate, and research since the end of Operation Desert Storm. Many groups have been brought 
together to shed light on the possible causes of these illnesses. These groups include committees 
and workgroups from the Defense Science Board, the National Institutes of Health, the 
Presidential Advisory Committee on Gulf War Veterans’ Illnesses, and the Institute of Medicine. 
Many of the comments and recommendations from these groups have focused on the 
environmental and chemical exposures that occurred during the war and how these exposures may 
have contributed to the illnesses seen in veterans today. 
Despite these review and research efforts, many questions regarding the nature of exposures 
encountered during the Gulf War remain. The etiologies of the illnesses facing these veterans are 
also still unknown. The relationship between these illnesses and other conditions, such as chronic 
fatigue syndrome and multiple chemical sensitivity, is not completely understood. Researchers 
and clinicians need ways to properly classify illnesses among Gulf War veterans. There is also 
need to investigate the synergistic effects of multiple chemical and environmental exposures and 
to identify the possible mechanisms leading from exposure to health outcomes. 
From February 28 through March 2, 1999, the Centers for Disease Control and Prevention (CDC) 
and other agencies of the Department of Health and Human Services (HHS) brought together 
scientists, clinicians, veterans, veterans’ service organizations, Congressional staff, and other 
interested parties to discuss and make recommendations regarding the direction of future research 
on undiagnosed illnesses among Gulf War veterans and the possible links between these illnesses 
and multiple chemical and environmental exposures. At this meeting, The Health Impact of 
Chemical Exposures During the Gulf War: A Research Planning Conference, participants 
worked together to address research needs in the areas of pathophysiology, assessment and 
diagnosis of illnesses, treatment, and prevention of illness in future deployments. Appendix A 
contains a list of all registered conference participants. 
10
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This meeting was held in response to a Congressional request that HHS examine the role of 
chemical exposures in the illnesses being reported by Gulf War veterans (1). Specifically, 
Congress believed it would be useful to support research in the areas of multiple chemical 
sensitivity, the definition of individual genetic differences in the ability to metabolize 
environmental agents commonly encountered during the Gulf War, and the development of a 
better understanding of how multiple exposures of chemicals interact to exert their toxicity (2). In 
addition, Congress emphasized the need for treatment trials that use treatment approaches being 
developed in the public and private sectors for illnesses resulting from chemical and other 
environmental exposures. 
An Executive Planning Committee, composed of representatives from CDC, HHS’s Office of 
Public Health and Science, the National Institutes of Health, and the Agency for Toxic Substances 
and Disease Registry, was formed to oversee planning for the conference. Members of the 
Executive Planning Committee are listed in Appendix B. The Executive Planning Committee 
emphasized the importance of obtaining broad public input both during the planning process and 
during the actual conference. As part of this public outreach, on July 21, 1998, a public meeting 
was held to obtain individual input from veterans, advocates, and scientists regarding the format 
and agenda for the conference. More than forty individuals were brought together and asked to 
provide their opinion on the types of topics that should be discussed at the conference and to give 
their recommendations regarding potential speakers and conference participants. Participants in 
the public planning meeting are listed in Appendix C. 
One recommendation made during the July planning meeting was that it would be useful to 
circulate, before the conference, a background document which would provide an overview of the 
research literature relating to Gulf War health issues. This background document was produced 
by an independent contractor, Syracuse Research Corporation, and provides an excellent resource 
on Gulf War health issues (3). It includes an overview of the exposures and health outcomes of 
concern to Gulf War veterans and reviews the research effort that has examined these health 
problems. This background document was distributed in advance of the conference to all persons 
who preregistered. Two additional documents were also distributed. These included a special 
issue of the journal Environmental Health Perspectives containing papers presented at the 
Workshop on Experimental Approaches to Chemical Sensitivity held September 20-22, 1995 in 
Princeton, New Jersey (4), and the Annual Report to Congress on Federally-sponsored Research 
on Gulf War Veterans’ Illnesses for 1997 prepared by the Research Working Group (RWG) of 
the Persian Gulf Veterans Coordinating Board (5). The background document can be accessed 
on the Internet at http://www.cdc.gov/nceh/ 
meetings/1999/gulfwar/. The current RWG’s Annual Report to Congress can be accessed at 
http://www.va.gov/resdev/pgulf98/gwrpt98.htm. 
Using feedback received during the July planning meeting, the Executive Planning Committee 
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a veterans’ forum.  The conference agenda is provided in Appendix D. The plenary sessions were 
meant to provide background information and to stimulate dialog on research questions. The 
plenary sessions included an overview of research findings regarding the health impact of the Gulf 
War, a panel discussion of the experience of Gulf War veterans, a series of presentations on the 
possible health outcomes of low-level chemical exposures focusing on nervous system, immune 
system, and pulmonary system outcomes, a series of panel discussions on research and clinical 
findings regarding multiple chemical sensitivity among Gulf War veterans and civilian populations, 
a series of presentations on possible mechanisms of action of chemical exposures, and a panel 
discussion on methodological considerations in studying the health impact of chemical exposures 
during the Gulf War. 
The concurrent workgroups were asked to develop research recommendations in four areas: 
pathophysiology, etiology, and mechanisms of action, chaired by Dr. Barry Wilson of the 
University of California at Davis; assessment and diagnosis, chaired by Dr. Roberta White of the 
Boston Veterans Affairs Medical Center; treatment, chaired by Dr. Benjamin Natelson of the 
New Jersey Medical School and the East Orange Veterans Affairs Medical Center; and 
prevention, chaired by Dr. Melissa McDiarmid, of the University of Maryland and the Baltimore 
Veterans Affairs Medical Center. Additional workgroup members were selected to bring a 
variety of experience and expertise to the process of developing research recommendations and 
included scientists and non-scientists, government and non-government representatives, and U.S. 
and international researchers. Workgroup members are listed in Appendix E. 
In developing the agenda, the Executive Planning Committee made a concerted effort to structure 
the meeting to allow for maximum public input and for interaction between veterans and 
scientists. An evening session, the veterans’ forum, was held to provide an opportunity for 
veterans to discuss their concerns with the workgroup chairs. Veterans used this opportunity to 
present their individual health concerns and experiences in seeking treatment and their 
suggestions regarding research priorities and alternative treatment approaches. The workgroups 
were also structured to ensure audience participation. Each workgroup met four times. The first 
session focused on workgroup member presentations, while the second session was devoted to 
audience input. Research recommendations were developed during the third and fourth 
workgroup sessions. To foster the exchange of information outside of the plenary and workgroup 
sessions, conference planners set aside space in a central location for audience members to 
distribute information. 
Each workgroup was asked to develop research recommendations that addressed specific issues. 
For the pathophysiology workgroup, these issues included synergistic and subclinical effects of 
chemicals, genetic susceptibility, biomarkers of susceptibility and exposure, and appropriate study 
methods. The assessment and diagnosis workgroup was asked to focus on case definition, 
overlap of conditions, the role of chronic, multi-system conditions, biomarkers of illness, optimal 
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workgroup was asked to focus on appropriate treatment paradigms, rehabilitation approaches, 
health care opportunities, education of physicians, and appropriate study methods. The 
prevention workgroup was asked to focus on health education and risk communication, and to 
examine approaches to environmental assessment, biomonitoring, and health preparedness. The 
workgroups were free to use whatever approach they found useful for developing research 
recommendations. In some cases there was considerable disagreement among workgroup 
members on the direction of the recommendations. Thus, the final recommendations of the 
workgroups were not necessarily endorsed by all workgroup members. 
This report summarizes the outcome of each of the four workgroup sessions. To develop this 
report, the Executive Planning Committee reviewed the transcripts of the conference. The 
transcripts from the conference are available on the Internet at http://www.cdc.gov/nceh/ 
meetings/1999/gulfwar/. Chapters 2 - 5 present the specific research recommendations developed 
by each workgroup. The research recommendations included in these chapters represent the 
deliberations of the workgroup participants and do not necessarily imply endorsement by CDC or 
any other federal agency or endorsement by the veteran or scientific community as a whole. 
Although the workgroups were asked to focus on research recommendations, some 
recommendations reflect clinical care, administrative, or policy issues. No attempt was made to 
filter non-research recommendations from this report. Chapter 6 provides a discussion of the 
workgroup deliberations and attempts to place the research recommendations in the context of 
current Gulf War research activities. A summary of the workgroup members’ presentations and 
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Chapter 2 
Workgroup 1: Pathophysiology, Etiology, and Mechanisms of Action 
Background: 
The workgroup that convened to examine pathophysiology, etiology, and mechanisms of action as 
related to Gulf War veterans' health concerns established several objectives governing its 
recommendations for research. Research in this area should be focused on identifying the events 
or environmental agents precipitating Gulf War illnesses, identifying the biochemical and 
physiological bases of Gulf War veterans' symptoms, identifying the mechanisms leading from 
exposure to symptoms, and establishing the scientific bases for treatment strategies for Gulf War 
illnesses. 
There are a variety of exposures recognized to have been encountered by individuals in the Gulf 
War theater. Many, if not most, of these exposures are already the subject of extensive study as 
potential contributors to the development of health effects in Gulf War veterans. It was 
emphasized by the workgroup that both individual exposures and interactions between various 
exposures need to be studied. The list of exposures of concern includes: 
• Depleted uranium (chemical and radiological effects). 
• Pyridostigmine bromide. 
• Vaccines and experimental adjuvants. 
• Nerve and blister agents, especially at low levels. 
• Biological warfare agents. 
• Heavy metals (e.g., lead). 
• Pesticides (e.g., organophosphates, pyrethroids, lindane). 
• Insect repellents (DEET). 
• Petroleum (e.g., solvents, fuels, Kuwaiti crude). 
• Oil fires (e.g., soot, oil rain; composition and concentration). 
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• Carbon monoxide. 
• Contaminated fine sand (bioactive properties). 
• Chemical Agent Resistant Coating (CARC) paint. 
• Heat, exertion, and other stresses. 
• Infections (fungi, viruses, etc.). 
To explore the most plausible etiological hypotheses concerning diagnosed diseases and 
unexplained multi-symptom illnesses noted among Gulf War veterans, the pathophysiology 
workgroup emphasized the need for multidisciplinary research efforts. The research 
recommendations include both short-term goals of immediate relevance to the understanding and 
treatment of unexplained illnesses of Gulf War veterans, and longer-term goals that include 
building a foundation of knowledge that can be used to understand and, hopefully, prevent 
environmental disorders in future generations. 
Research Recommendations: 
I. Human Studies: 
Studies of veteran populations and other groups affected by similar exposures need to be 
continued and enhanced, to include, among other things, an examination of a wide range of 
physiological systems and endpoints to reflect the different symptoms reported by Gulf War 
veterans. The research effort should include neurological, central nervous system, neuromuscular, 
and aging studies; immunological and immunotoxicity studies; studies of the pulmonary and 
respiratory systems; circulatory and hematopoietic system studies; studies of dermal and 
gastrointestinal system involvement, especially as routes of exposure; and studies of birth defects 
(e.g. Goldenhar syndrome) and reproductive toxicity. Since many of the reported manifestations 
of illness are similar to conditions which appear to affect men and women differently in civilian 
populations, gender differences in these endpoints should also be examined. Exposure assessment 
in these studies will be a critical contribution to establishing a link between exposures and disease. 
Specific recommendations for human studies include: 
1) Analysis of deployment cohorts:  Future studies should examine the interaction of 
physical, chemical, and other stressors on multiple organ systems. This research should 
include an assessment of the proportion of cases of unexplained illness as a function of 
length of time spent (and possibly location) in the Gulf in order to segregate separate sets 
of exposures to chemicals, physical agents, and psychological or physical stressors and to 
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determine the associations with health or disease. There should be a comparison of Desert 
Shield veterans, Desert Storm veterans, and troops that arrived after the cessation of 
hostilities. 
2)	 Analysis of exposed Gulf War veteran populations from other countries and related 
experiences:  There is little information on country-specific prevalence of unexplained 
illness among veterans and why such illness was not reported by some coalition partners. 
Little or no research has been undertaken among the communities directly affected by the 
Gulf War conflict, and no international public health research has been carried out in Iraq. 
For a clear picture of the relationship between the adverse health effects of environmental 
exposures in the theater-of-war, it is imperative that every conceivable opportunity is 
taken to collect and synthesize relevant exposure and health information from other 
nations, including both allied countries and Iraq. Because veterans of all countries 
participating in the Gulf War sustained exposures of concern, there is no scientific basis 
for the exclusion of one party from study. The medical doors of countries involved in the 
Gulf War conflict now appear to be opening to international medical scientists committed 
to finding answers to common health problems. Credible evidence of a rare disorder 
occurring in a high incidence among Iraqi veterans could greatly affect understanding of a 
comparable illness among veterans of coalition forces. 
3)	 Studies of potential health effects of destruction of chemical warfare agents in the U.S.:
Current plans call for controlled destruction of a stockpile of chemical warfare agents at 
seven sites in the U.S. One proposal is to undertake prospective health assessments of 
communities impacted by sarin and mustard incineration at these seven sites before, 
during, and after incineration. 
4)	 Studies of potential health effects of pesticide exposures:  Studies of populations exposed 
to organophosphate pesticides that have mechanisms of neurotoxicity similar to those of 
some chemical warfare nerve agents can shed light on those health effects. 
5)	 Susceptibility studies:  Besides exposure, the other key component that determines health 
is a person’s individual susceptibility. In this context, susceptibility is a wide-ranging term, 
encompassing genetics, nutrition, gender, age, and other factors. Factors relating to 
susceptibility to any disease or exposure are still very poorly understood, but elucidating 
these factors may have the power to help us understand the incidence and distribution of 
illnesses among Gulf War veterans. Specifically, answering the question of whether low-
level exposures lead to neurotoxic and other health effects will depend on our 
understanding of the intrinsic toxicity of the chemical, the presence of other exposures, 
and the susceptibility of the person who is exposed. Our knowledge of the possible 
exposures and the physiological mechanisms involved in metabolizing these chemicals can 
suggest candidate genes for study. We can develop the tools for genetic screening for 
16
 
    Research Planning Conference Report 
polymorphisms among genes interacting with known risk factors (e.g., cholinesterases, 
porphyrinopathy). 
6)	 Chemical sensitivity studies:  Studies should examine toxicant-induced loss of tolerance in 
susceptible individuals as a possible explanation for some Gulf War symptoms. 
Susceptible people, following an initial exposure event, may lose specific tolerance and 
become sensitive to low level exposures of many different foods and substances. 
II. Animal Studies 
Controlled studies of exposure under laboratory conditions are only possible with animal models. 
Under these conditions, we can refine our understanding of clues obtained from human studies 
and gain insights that will lead to more effective treatment strategies. The use of transgenic 
animals is also valuable for determining the genetic components of responses to some exposures 
of interest. With the right animal models and exposure measures, we can answer some questions 
that cannot be easily asked in human studies; for instance, we can examine the interactions of Gulf 
War exposures with physical stress (exertion). Specific recommendations for animal studies 
include: 
1)	 Studies of synergistic effects of exposures. 
2)	 Studies of subclinical effects of exposures. 
3)	 Studies of low-level, chronic exposures. 
4)	 Studies of multi-generational exposures. 
5)	 Studies to develop animal models for chemical sensitivity and other conditions. 
6)	 Studies examining patterns of gene expression. 
7)	 Studies evaluating delayed expression of effects of environmental insults. 
8)	 Studies of sex differences in effects of chemical exposures. 
III. New Methodologies 
New tools are revolutionizing biomedical science and toxicology. These tools should be brought 
to bear on the study of Gulf War veterans’ illnesses.  Recommendations regarding new 
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methodologies include: 
1)	 QSAR approach to molecular interactions:  Studies should make use of quantitative 
structure-activity relationship modeling to predict chemical toxicity in relevant receptor 
systems (using combinatorial chemistry, computer/information technology, statistical 
modeling and biological information). 
2)	 Development of biomarkers of exposure, susceptibility, and effect: Biomarker tools are 
needed for exposure assessment in human studies, for linkage of exposures to preclinical 
outcome measures, and for use in animal studies. Studies should be conducted to identify: 
•	 biomarkers of susceptibility to chemical sensitivity and other predispositions to 
disease. 
•	  biomarkers of stress, including physical exertion and heat stress. 
•	 biomarkers for chemical agent exposures. 
3)	 Anti-sense DNA technologies:  In cases where expression of a specific gene(s) is 
determined to be a necessary step for development of health effects, use of anti-sense 
DNA has potential as a novel treatment strategy (for instance against 
acetylcholinesterase). 
4)	 Other new methodologies:  Other approaches that should be explored include: 
•	 Multifactorial statistical models (gene-environment interactions, exposure 
confounders). 
•	 Transgenics and knockouts for studies of genetic susceptibility. 
•	 Alternatives to animal systems (cell and tissue culture) 
•	 Imaging techniques. 
IV. Special Needs 
1)	 Centralized Gulf War research library and data repository:  The workgroup unanimously 
endorsed a recommendation for the establishment of a centralized research library and data 
repository that would collect research proposals and results and maintain them in a format 
that would be easily accessible and searchable electronically. 
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2) Controlled-environment medical unit(s):  This proposal is for a controlled isolated 
hospital environment to reduce everyday exposures as low as practicable. Sensitive 
individuals can be placed in this environment and challenged with different substances. 
V. Research Oversight 
To ensure and enhance continuation of the present cooperation between health professionals and 
veterans, the workgroup recommends that a non-governmental national committee be established 
to advise on the selection and implementation of these research recommendations. This 
committee is not intended to replace the governmental interagency Persian Gulf Veterans 
Coordinating Board, but rather, to provide a mechanism by which the interests of Gulf War 
veterans can be heard on a continuing basis by a non-governmental group. A possible venue for 
this committee is the National Research Council (a non-governmental body with a reputation for 
independence), with joint participation among the National Academy of Sciences (Board on 
Toxicology and Environmental Health Hazards), the Institute of Medicine (including the Medical 
Follow-up Agency), and representatives of Gulf War veterans' organizations. Alternatively, a 
federally sanctioned committee could be established under which representation from the various 
interested parties would be mandated. This committee could be modeled on the advisory group 
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Chapter 3 
Workgroup 2: Assessment and Diagnosis 
Background: 
The assessment and diagnosis workgroup was charged with developing research 
recommendations covering a wide range of issues including case definition; chronic multi-system 
conditions, such as chronic fatigue syndrome (CFS), multiple chemical sensitivity (MCS), and 
fibromyalgia (FM); overlap of these conditions among Gulf War veterans; optimal methods for 
diagnosis; and validation of assessment approaches. 
The workgroup recognized that Gulf War veterans were presumed to be in better health than the 
general public and to be healthy before they were deployed. Veterans were exposed to a 
combination of wartime and environmental factors that are known to have health risks. In other 
occupational groups, such as firefighters, police, and miners, who have exposures to complex 
environmental hazards, it is often recognized that these exposures affect health. The workgroup 
recommended that an interim assumption of service connection be established pending better 
characterization of the illness so that veterans can obtain appropriate treatment and compensation. 
Research Recommendations: 
I. Case Definition 
1)	 Case definitions for illnesses among Gulf War veterans must be developed in a way that 
allows comparison to case definitions already existing for chronic multi-system conditions. 
The establishment of methods for comparing case definitions would allow for 
identification of areas of overlap and possible new etiologies or conditions among this 
population. 
2)	 All definitions for Gulf War illnesses should be described in detail in research studies so 
that all parties understand the criteria used in establishing conclusions from the work. 
Efforts should be made to examine and compare the methods used for diagnostic criteria 
within studies. Such efforts allow for development of the most robust case definition. 
3)	 All subtypes of Gulf War related illnesses should be based on available data. If individual 
symptoms or symptom clusters cannot be placed into a diagnosis or disorder, these 
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II. Chronic Multi-System Disorders 
Many of the symptoms reported by Gulf War veterans overlap with other chronic multi-system 
disorders such as MCS, FM, and CFS. Recommendations of the workgroup included some 
specifics on these disorders which should be explored in connection to Gulf War veterans in 
particular. 
1) Research is needed to examine the prevalence and overlap of a number of conditions 
which resemble the illnesses of Gulf War veterans. These conditions include CFS, FM, 
MCS, somatization disorder, post-traumatic stress disorder, sick building syndrome, and 
neurasthenia. The prevalence of these conditions should also be determined in other 
relevant populations. Such populations might include indigenous populations of the area, 
other coalition forces, and active duty personnel who prepared for deployment but never 
actually deployed. 
2) Case-control studies should be carried out among Gulf War veterans to better assess the 
occurrence of multi-system disorders in this population. These studies should include the 
examination of field data on casualties and illnesses affecting soldiers in the theater of 
operation. While much of these data may be lost, certain data, such as some inpatient 
records, may be retrievable. 
3) Novel techniques, such as laboratory models (e.g., environmental control units), functional 
imaging techniques, and development of biomarkers in exposed populations, need to be 
explored in an effort to understand the illnesses experienced by Gulf War veterans. 
Currently there are no animal models to study these chronic multi-system disorders. The 
workgroup encourages the development of novel animal models to study issues pertinent 
to these disorders. Examples of possible animal models may include the development of 
new animal strains to express unique polymorphisms which may be relevant to exposure 
effects. 
4) Investigations should be conducted into barriers that may exist within the Department of 
Veterans Affairs (VA) which may deter physicians from using the diagnosis of chronic 
multi-system disorders with patients under their care. These investigations should include 
an assessment of the reliability of the VA application of chronic multi-system diagnoses 
and the potential for training physicians in the proper application of new diagnostic 
methods and procedures. 
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III. Well-Defined Disorders 
The workgroup put forth a number of recommendations encouraging the use of well-defined 
criteria when investigating and assessing conditions among Gulf War veterans. Any diagnosis for 
research purposes, as much as possible, should be achieved through use of accepted gold standard 
evaluations. 
1)	 Medical disorders should be classified by International Classification of Diseases, version 9 
(ICD-9) criteria; psychiatric disorders should be classified by Diagnostic and Statistical 
Manual of Mental Disorders, version IV (DSM-IV) criteria. All adverse reproductive 
outcomes should fall under the Centers for Disease Control and Prevention (CDC) 
classification of birth defects, and all cancer diagnoses should be made according to 
appropriate Surveillance, Epidemiology, and End Results (SEER) classification. 
2)	 Research studies should document the existence of multiple disorders using standard 
criteria to characterize coexisting conditions. These conditions could include, but may not 
be limited to, physical trauma, infectious diseases, autoimmune disorders, vocal chord 
dysfunction, reactive airways dysfunction syndrome (RADS)/asthma, rhinitis, and 
mortality. Any research on MCS should consider overlap with other disorders which have 
well-defined ICD-9 criteria. 
IV. Overlap of Conditions 
The workgroup realized the tremendous potential of overlap in chronic multi-system conditions 
and recommended careful study design when diagnosing such disorders. 
1)	 When assessing overlapping conditions, investigators should define the exclusionary 
criteria used for labeling subjects with each condition, and use standard criteria for 
diagnosing the condition whenever possible (clearly indicating the criteria that were used). 
Researchers must evaluate the overlap between specific chronic multi-system conditions 
and other such conditions as well as well-defined conditions. 
2)	 Investigators should develop and specify the methods by which they handle overlap in 
symptoms and overlap in diagnoses. 
3)	 Investigators should explore the determinants of patient treatment-seeking and assess the 
impact of treatment-seeking on the characteristics of study populations. Researchers are 
encouraged to explore characteristics of patients seeking care at different types of health 
care facilities. Additionally, it is important to carry out studies on non-treatment seeking 
populations. Such groups may be important in the determination of prevalence and may 
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have profound effects on conclusions of research into Gulf War illnesses. 
4)	 Studies should be conducted to examine the role of pre-existing disorders. Data need to 
be collected for the study of relationships between pre-existing disorders (both well-
defined and chronic multi-system disorders) and the expression of chronic multi-system 
disorders after Gulf War service. These data would help physicians better understand the 
influence of pre-existing conditions in the initiation or propagation of the disorders seen in 
Gulf War veterans. 
5)	 An additional area of research to be studied and evaluated is the role of gender in the 
development of disorders among Gulf War veterans. Some observations have shown that 
there is a higher rate of some conditions among males in the Gulf War veteran population 
than in other populations. Studies could be developed to investigate how these 
observations relate to current knowledge regarding disorders such as CFS and MCS. 
V. Biomarkers
 Biomarkers need to be studied in relation to both the illnesses among Gulf War veterans and 
other chronic multi-system disorders such as CFS, FM and MCS. 
1)	 Due to the long period of time which has passed since the Gulf War, particular emphasis 
should be paid to the development of biomarkers for past exposures. 
2)	 The study of existing biomarkers should continue and new research should be performed 
using existing biomarkers on combinations of chronic multi-system disorders. 
VI. Assessment and Diagnosis 
The workgroup had very specific recommendations related to the assessment and diagnosis of 
disorders when performing research on illnesses affecting Gulf War veterans. All of the 
recommendations for assessment and diagnosis would be considered long-term efforts due to the 
significant amount of time and amount of resources necessary to bring the recommendations into 
practice. 
1)	 Assessment techniques employed in research should reflect specific hypotheses about 
relationships between chemical exposures and structural changes or functional 
abnormalities. 
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compensated subjects should be conducted. 
3) Development of new laboratory tests of chemical effects is recommended. In order to be 
applicable, new tests must meet rigorous standards and studies should include evaluation 
of reliability, repeatability, validity, and specificity. 
4) Combinations of assessment and diagnostic techniques aimed at evaluation of the same 
organ structures should be employed in research. For example, a study of the central 
nervous system might include structural imaging, neuropsychological testing, 
neurophysiologic measures, and functional imaging. 
5) Comprehensive assessment may be required to accurately measure variables of interest, to 
evaluate confounders, and to assess the same domains in different ways. Since there is the 
possibility of significant overlap in the disorders affecting Gulf War veterans, care needs to 
be taken when assessing patients. Thorough examination and accurate testing of variables 
will help eliminate problems when identifying illnesses in this veteran population. 
6) Clinically non-routine assessment probes are recommended for consideration in research. 
This would include such procedures as use of environmental control units, carbon dioxide 
challenges, blind olfactory challenges, and autonomic nervous system assessment. 
7) Use of tests for which there are normative and validity data for the general U.S. 
population or carefully matched control groups is recommended. 
8) A research project assessing longitudinal health changes across time in a normal 
population is suggested. The illnesses facing Gulf War veterans are not unlike disorders in 
the general population and studies looking at the changes in health over time in normal 
individuals would provide a valuable basis for comparison. 
9) Careful assessment of confounders and effect modifiers is necessary. (For example, 
research should control for medication history.) Assessment of family members and 
significant others is recommended for independent verification of partner health outcome 
and risk factors in order to both ascertain whether there is a biological basis for symptom 
transmission and explore environmental exposure histories at home. 
10) Assessment of events following the death of a Gulf War veteran is suggested in order to 
track factors that might influence mortality and the death certificate diagnosis. The 
workgroup was not aware of any autopsy studies examining causes of death in Gulf War 
veterans. Therefore, protocol driven autopsy studies are recommended following the 
death of a Gulf War veteran. 
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VII. Validation 
The workgroup recognized the importance of validation of study results and recommended that 
the identification of appropriate populations for validation and cross validation of study results on 
Gulf War populations should consider groups deployed elsewhere, non-deployed military 
personnel, and other exposed populations. It should be recognized that military controls may not 
always be appropriate because the controls may have the same exposures as deployed veterans. 
Care should be taken to identify the appropriate control group when designing research protocols. 
Many instruments are available for investigating illnesses among Gulf War veterans, but most of 
these were not designed specifically for this purpose. It is recommended that standardized 
instruments revised for use in Gulf War populations be re-validated. Additionally, while the use 
of convenience samples to develop hypotheses about Gulf War related disorders is appropriate, 
the findings from these studies should be validated using larger representative samples if 
provocative results are obtained. 
Validation of a case definition can be carried out at three levels (from lowest to highest): 
• derivation on a single Gulf War population. 
• replication in a second Gulf War population. 
• association of findings with appropriate biomarkers. 
VII. Other 
Lastly, the workgroup made a general recommendation. Since it is necessary to use the most 
current and relevant information, the Department of Defense should continue to declassify and 
disseminate all relevant classified scientific field investigations and clinical studies to enable a 
better understanding of Gulf War veterans’ illnesses and their possible causes.  
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Chapter 4 
Workgroup 3: Treatment 
Background: 
The treatment workgroup was asked to address five areas: appropriate treatment paradigms, 
approaches to rehabilitation, healthcare opportunities for veterans of the Gulf War, education of 
physicians, and appropriate study methods for treatment trials. The workgroup emphasized the 
need for increasing current treatment options for Gulf War veterans, using research methods to 
assess treatment efficacy, and assessing veteran satisfaction with treatment. The workgroup 
developed additional long-term recommendations focusing on development of therapeutic options 
by controlled clinical trials, with evidence-based trials (hypothesis-based ideas with supporting 
data) having the highest priority. In addition, the need for new strategies to educate physicians 
and to assess the effectiveness of the education was emphasized by the workgroup. 
The treatment workgroup developed recommendations in four areas: pharmacologic therapy, non­
pharmacologic approaches, treatment regimens based on chemical intolerance, and “macro” issues 
(the patient-physician relationship, interrelation of the individual to the organization, veterans’ 
satisfaction with care, and educating physicians). The workgroup members attempted to focus on 
treatment approaches that were evidence-based and could be tested with appropriate research 
designs. 
Research Recommendations: 
I. Pharmacologic Therapy 
There is an urgent need for research concerning treatment approaches for Gulf War veterans. 
Several potentially promising approaches to treatment are not supported by the degree of empiric 
support or pilot data that is typically required. When such proposals are being considered for 
funding, special peer review panels should be assembled that understand these unique 
circumstances. Funding should be considered for well-conceived, scientifically sound proposals 
that may lack empirical supporting data. As research progresses, if a subset of Gulf War veterans 
is identified that has a specific cause for their symptoms and an appropriate treatment, then this 
testing should be considered for all symptomatic veterans. 
1) Studies should be conducted to examine the efficacy of pharmacologic therapy to treat 
specific symptoms of Gulf War veterans. Assessment of treatment efficacy should include 
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experiencing significant symptoms at the end of trials should be considered for subsequent 
treatment trials using other available medications. Examples for treatment of pain and 
cognitive dysfunction include the following (other focused symptoms should be treated 
using a similar approach): 
•	 Pain – An open trial aimed at veterans with untreated pain to sequentially examine 
the efficacy of low doses of medications that have been found to be effective in 
reducing pain among other patient populations. Examples include low dose 
antidepressants (e.g., venlafaxine) and analgesics (e.g., tramadol). 
•	 Cognitive symptoms – A trial examining the efficacy of bupropion (a selective 
dopamine-reuptake inhibitor) and pemoline (a psychostimulant) in improving 
cognitive symptoms in persons with these conditions. 
2)	 Studies should be conducted to test the hypothesis that neurally-mediated cardiovascular 
changes may be responsible for symptoms of some Gulf War veterans. Therapeutic 
considerations for such a trial include fluid and sodium repletion, beta-blockers, 
mineralocorticoids, and calcium channel blockers. 
3)	 Since sub-clinical hypothyroidism and hypoadrenalism may occur in patients with 
fibromyalgia and chronic fatigue syndrome, trials examining the efficacy of low-dose 
replacement of these hormones among Gulf War veterans with unexplained symptoms are 
recommended. 
4)	 Nutritional supplements and vitamins are purported to be effective for a number of the 
conditions and symptoms affecting Gulf War veterans. Governmental agencies should 
form a committee to examine which nutritional interventions would be most likely to be of 
benefit, and then fund pilot studies to examine the effectiveness of these therapies. 
II. Non-pharmacologic Therapies 
Some of the major challenges faced when attempting to maximize the use of effective non-
pharmacological therapies include matching therapies to the specific needs of the veteran, and 
ensuring that a wide range of therapies is available and consistently and appropriately 
implemented in the course of routine health care delivery. The usual structure of primary care and 
specialty care features a 10-15 minute acute care visit with a physician. The prudent clinician 
rapidly narrows the focus of the visit to one or two “chief complaints.”  Often, physicians target a 
certain area of the veteran’s health concerns and prescribe one or more pharmacological 
treatments, which sometimes cause unexpected side-effects. For veterans with complex health 
needs, this approach is unsatisfying at best and disabling at worst. The workgroup recommends 
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that, rather than focus on specific non-pharmacological therapies, clinicians and researchers 
should develop a more comprehensive and population-based approach to non-pharmacological 
care. 
1)	 Conduct a pre-care needs assessment:  This assessment should target all Gulf War 
veterans, including active duty members and reservists not currently covered in either the 
Department of Veterans Affairs (VA) or the Department of Defense (DoD) health care 
systems. The needs assessment could be completed using some combination of paper and 
pencil survey, semi-structured telephone interview, and/or clinician administered 
systematic assessment. Needs assessments must emphasize the veteran’s perspective. 
Areas of inquiry should include current communication modalities available for veterans 
and their health care systems to exchange information (e.g., Internet access, personal 
computer, current and permanent address, other available points of contact); perceived 
need for health information; need for assistance with activities of daily living; need for 
specific types of health care; access to care; barriers to care (including the benefits 
assistance process); recent levels of fatigue, pain, sleep, and cognitive difficulties, physical 
health concerns, health-related quality of life, satisfaction with care, and illness-related 
psychosocial distress; need/desire for specific non-pharmacological therapies not currently 
available; and suggestions for improvement in current health care. 
2)	 Develop pre-care guidance on self-care strategies:  Gulf War veterans should be targeted 
in a population-based fashion for mailed self-help guides. All veterans should receive 
either standard self-help literature focused on common veteran health concerns and needs, 
or literature tailored to their needs as identified on the needs assessment. The added 
benefit of the tailored literature would be estimated using reassessments of all or some of 
the areas of inquiry described in the pre-care needs assessment. 
3)	 Use a primary care and collaborative primary care approach to treatment:  Gulf War 
veterans responding to the needs assessment should be given membership in the primary 
care practice team’s patient panel for routine primary care follow-up. The practice team 
would clinically assess, discuss together, and plan the short- and long-term care of 
responding veterans. Level of care should be matched to each veteran’s needs. For those 
veterans with complex health care needs or for those whose health concerns persist in 
spite of primary care follow-up and implemented medical strategies, collaborative efforts 
involving combinations of health information materials (brochures, books, tapes), and non-
pharmacological strategies implemented by clinicians other than physicians on the primary 
care practice team (e.g., nurses, occupational therapists, physical therapists, social 
workers, psychologists) would be emphasized in a planned, explicit, and structured 
delivery approach. This level of care should be compared to usual VA and DoD care or 
other less intensified or coordinated approaches to VA and DoD primary care. Outcomes 
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4) Provide intensive specialized care for chronic symptoms of unclear etiology:  When 
disability persists despite these previous elements of care, more intensive programs 
emphasizing rehabilitative measures should be tested, such as the current VA 
exercise/behavioral treatment trial. Other models may be borrowed from efforts currently 
being successfully used for individuals with chronic illnesses (e.g., fibromyalgia, chronic 
fatigue, chemical sensitivity and related syndromes, and head injury). 
5) Evaluate novel, new, or promising non-pharmacological treatment modalities: Pilot 
studies followed by single center and multi-center randomized clinical trials should be used 
to evaluate novel, new or promising non-pharmacological modalities. Some modalities of 
interest include acupuncture, chiropractic, modified psychosocial interventions such as 
cognitive-behavioral therapies used for other physically symptomatic illnesses, sauna, 
dietary, and creative arts approaches. 
6) Develop a coordinated quality improvement program:  This program should encourage 
health services research and research into innovative efforts to integrate non-
pharmacological treatments into the usual provision of VA and DoD primary and specialty 
care. 
III. Treatment Regimens Based on Chemical Intolerance 
Anecdotal evidence suggests that detoxification-based treatment programs have been effective in 
reducing symptoms of some Gulf War veterans. Detoxification is a treatment involving sauna 
baths, stringent exercise, and vitamin therapies. Other veterans report that trial and error testing 
has revealed intolerance to chemical inhalants, foods, and drugs. Further, veterans report that 
avoiding these substances improves their symptoms. This elimination routine has been advocated 
by some practitioners for more than fifty years. Other veterans report that a combination of these 
therapies increases their health and well-being. The enthusiasm shown for these therapies by 
veterans who have undertaken them suggests that controlled trials should be conducted to 
determine their efficacy. Criticism has been made of the practice of prescribing multiple drugs for 
symptomatic relief of Gulf War veterans with unexplained illnesses, and some have suggested that 
adverse reactions to multiple drugs is a factor in the these illnesses. This hypothesis is easily 
tested by a drug avoidance protocol. 
In order to rule out potential biases, these studies should be conduced in a controlled and blinded 
fashion. In addition, patients with possible infectious disease, specific toxicological syndrome, or 
other well-defined medical illnesses that would explain symptoms should be excluded. Pre-, 
post-, and intra- treatment assessments should be conducted. Evaluation procedures should 
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illness, quality of life, and neuropsychiatric symptoms. For the detoxification protocols, there 
should be monitoring of levels of chemical in adipose tissue, serum, urine, sweat, and any 
abnormal body secretions. Specific chemical intolerance study recommendations include: 
1)	 Conduct a treatment trial to examine the efficacy of a detoxification routine consisting of 
saunas, stringent exercise, and vitamin therapies at a clinic specializing in this technique. 
2)	 Examine the efficacy of a physician-directed, home-based trial of testing of intolerance to 
chemical inhalants, foods, and drugs, followed by avoidance of those chemicals to which 
there is sensitivity in order to evaluate if health is substantially improved. 
3)	 Conduct a treatment trial to examine the effectiveness of a program combining 
detoxification with trial and error testing of intolerance to chemical inhalants, foods, and 
drugs, followed by avoidance of those chemicals to which there is sensitivity in order to 
evaluate if health is substantially improved. 
4)	 Conduct a double-blinded, placebo-controlled trial of drug elimination with veterans who 
are taking multiple drugs for symptomatic relief of unexplained symptoms. Clearly, this 
study should exclude all veterans taking essential medications for conditions such as 
diabetes, heart disease, and hypertension. 
5)	 Depending on the efficacy of the pilot studies described above, one or more environmental 
control units should be constructed to diagnose and treat Gulf War veterans who may 
have multiple intolerances to those foods, chemicals, and inhalants found to exacerbate 
symptoms. These studies should integrate detoxification regimes as appropriate. 
IV. Macro Treatment Issues 
The effectiveness of Gulf War related treatment trials and other research programs would be 
maximized by establishing a central body to coordinate communication, education, and outreach 
efforts and to ensure that Gulf War veterans are being treated with dignity and respect. This body 
should facilitate communication channels among veterans, health care professionals (especially 
VA or DoD Gulf War coordinators), researchers, and administrators. Information should be 
used to expedite the identification, dissemination, and implementation of therapies that are 
effective in order to match veterans with specialized care centers for specific conditions, and to 
ensure that health care providers are aware of the most current information on Gulf War related 
illnesses. 
1)	 Establish a Logistics and Communication Network Center:  This center should consist of 
appropriate parties (e.g., researchers, health care providers, veterans, and members of 
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advocate groups) committed to enhancing communication, outreach, and education 
between groups. To support the concept and the adoption of this recommendation, the 
center may be modeled in a manner similar to the National Center for Posttraumatic Stress 
Disorder. This center should maintain a central data bank of completed and ongoing 
research protocols and establish an Internet Website and newsletter. 
2)	 Conduct focus groups:  Focus groups should be conducted at VA and DoD sites to assess 
Gulf War veterans’ health care needs and health care provider concerns.  Gulf War 
coordinators should interface between the focus groups and the Logistics and 
Communication Network Center. 
3)	 Develop, evaluate, and implement protocols focusing on communication and education 
issues:  These protocols should include education of veterans, family members, and 
veterans’ advocates, as well as VA, DoD, and other appropriate health care providers, 
staff, and administrators. The effort should address issues such as needs assessment of 
potential patients, identification and recruitment of candidates for study, communication 
through newsletters and Internet sites to update veterans and health care providers on 
effective treatment protocols and other Gulf War related information, development of self-
help education for veterans and family members, development of outreach programs for 
multi-disciplinary teams of health care providers, and examination of administrative 
processes that may be stumbling blocks for high-level quality of health care delivery. 
4)	 Other macro treatment issues:  Other macro treatment recommendations include: 
•	 Develop mechanisms to update primary care practitioners so they are 
knowledgeable about emerging exposure information. 
•	 Monitor the availability of effective treatments/drugs to be considered for 
compassionate use. 
•	 Develop mechanisms to monitor the quality of care of Gulf War era veterans. 
•	 Create a virtual library of high quality patient information. 
•	 Develop methods for patients to have greater access to their medical records. 
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Chapter 5 
Workgroup 4: Prevention 
Background:
 The prevention workgroup was asked to focus on four areas: health education and risk 
communication, approaches to environmental assessment, biomonitoring, and preparedness 
against chemical exposures. The workgroup relied on basic public health principles to develop 
recommendations and to establish priorities. That is, in structuring an approach to identifying 
prevention research needs, the workgroup considered the severity of the hazard, the number of 
people potentially exposed, the availability and feasibility (technical and economic) of 
interventions, and chances for success with existing interventions. The workgroup also 
emphasized the importance of relying on well-tested models and research tools, such as those 
currently used in occupational settings. Most important to the deliberations was the occupational 
and public health concept of "hierarchy of control strategies." This concept emphasizes the 
importance of developing an ordered hierarchy of prevention and intervention strategies. The 
implementation of these strategies should move from lower order items to higher order items with 
each step providing additional levels of protection. The prevention workgroup used the 
following elements of the hierarchy of control strategies as a framework for specific research 
recommendations: 
Hierarchy of Controls 
1 Substitution 
2. Engineering Controls 
3. Administrative Controls 
A. Health Education 




4. Work Practices 
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Research Recommendations: 
General Prevention Principles To Be Considered When Formulating a New Research Agenda
Three key prevention messages should be considered when formulating a new research agenda: 
assess what has already been done, examine exemplary models of prevention strategies and 
outcomes, and identify data gaps for future prevention research approaches. 
1)	 Assess what has already been done: A critical first step is to evaluate previous efforts to 
determine the effectiveness of what has already been done. Such outcome research should 
focus on lessons learned, best practices, and evaluation research. Several interventions are 
already in place. The Department of Defense (DoD) and Department of Veterans Affairs 
(VA) must thoroughly assess these efforts when formulating policies and procedures for 
future deployments and follow-up strategies. For example, DoD maintains a central 
database repository, the Defense Medical Surveillance System, which consists of a system 
of linked databases containing medical information, personnel data, and deployment 
rosters. This system presents a key data source that would permit objective analysis to 
identify problem areas and critical needed improvements. However, collection of such 
data without attempts to assess and analyze the information will not lead to the necessary 
short-term and long-term prevention strategies that are possible. 
2)	 Examine exemplary models of prevention strategies and outcomes:  The second key 
approach is to assess other exemplary national and international models of strategies and 
outcomes. An issue that has hampered professionals in public health is lack of record 
linkage. The United Kingdom and Canada, because of their health care systems, can use 
record linkage to strive toward better health outcomes. Such basic structural record 
linkage creates possibilities that allow epidemiologic studies to be done. While operating 
in a different health care environment than either of these two countries, the U.S. will 
continue to have problems accessing critical health information until the record linkage 
issue is fully addressed. 
Other existing comprehensive safety and health management programs can suggest a 
framework for analysis. Existing programs in the military can be compared with other 
programs in occupational health in an effort to implement best practice standards or to use 
them as a marker for developing new programs. Well-implemented plans with defined 
procedures and internal audit systems to assess the deficiencies and limitations of the 
procedures are essential. 
3)	 Identify data gaps for future prevention research approaches:  In formulating future 
directions, prevention research should include identification of data gaps and measurement 
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content and process end points. A classic example is the development of vaccines that 
protect against debilitating disease. A content endpoint for effectiveness would be the 
basic laboratory and clinical research that identifies the best way to formulate vaccines. A 
process end point would be the outcome research that identifies the most acceptable way 
to administer vaccines to prevent illness in populations. 
Specific Recommendations Based on Hierarchy of Control Strategies 
I. Substitution 
If exposure to certain toxicants (or other hazards) can be eliminated or other less hazardous 
substitutes provided to protect the service member, then other interventions would not be 
necessary. Research is needed to: 
1) Identify less toxic substances and their interactive effects. 
2) Restrict the need for use of multiple pesticides. 
3) Optimize vaccine potency, formulation, dose, and duration. 
Research to examine the interactive effects of environmental exposures is critical and a fruitful 
area for laboratory research. In addition to lowering potential health risks, limiting exposure to 
environmental hazards, such as restricting the number of pesticides that are in use, would simplify 
the gathering of exposure histories. Improvements in vaccines may reduce service members’ 
concerns about potentially negative effects sometimes associated with vaccinations. 
II. Engineering Controls 
Engineering controls are applied when the hazard cannot be substituted or removed. A physical 
barrier protects service members with design features that do not require the physically exposed 
person to consciously do something to protect him or herself. There is a built-in presumption of 
protection because the situation itself is engineered to eliminate the hazard. While the unique 
nature of military operations makes this aspect difficult, preplanning in design of equipment and of 
weapon systems can help. Research is needed to: 
1)	 Evaluate the current design and operation of equipment and material in order to reduce 
hazards to service members. 
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Human factors need to be considered when designing effective engineering controls. Additional 
research is needed to better understand how humans cognitively process and act upon objective 
information under normal conditions and under conditions of high stress. Such knowledge is 
essential for effective design of human-machine or human-instrument interfaces. 
III. Administrative Controls - Health Education 
Research is needed to improve the delivery and effectiveness of health education in military 
settings. This should include research to: 
1)	 Identify and segment key audiences. 
2)	 Determine appropriate instructional strategies. 
3)	 Identify barriers to understanding the importance and impact of health education messages 
on readiness. 
Health education efforts should focus on identifying the various populations for outreach. In the 
military setting, there are much larger audiences than just the service member, including family 
members and other potentially affected people. From a readiness point of view, the importance of 
preparing service members and their families needs to be recognized. For example, information 
on reproductive health issues is one content area where health information should be enlarged. 
Another major issue is determining the best channels for transmitting health education 
information, including identifying the types of information sources that are credible to specific 
audiences. Knowledge regarding effective instructional strategies is important for decision-
makers like field commanders, who have to make strategic decisions. These should be informed 
strategic decisions, especially if there must be tradeoffs between military strategy and exposure to 
hazardous conditions. Theoretically, during the Gulf War, health information was to have been 
communicated. However, clearly there were problems with this health education effort. 
Prevention research is needed to identify the barriers to veterans’ understanding of health 
education messages and the impact of such barriers on readiness. 
IV. Administrative Controls - Risk Communication 
Providing effective communication of scientific uncertainty is extremely difficult. With the reality 
that nothing is assured and experience is not the same from person to person, complex 
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1) Develop and test message content and channels. 
2) Identify multiple audiences and information sources. 
3) Assess effective communication of scientific uncertainty and technical information. 
4) Assess comprehension, utility, and value of risk information. 
5) Identify methods to communicate comparative risk issues. 
It is important to provide information on real versus perceived risks. A significant example of this 
is the communication of information on reproductive health issues. It is also important to identify 
the channels through which people are obtaining information: print media, broadcast media, fact 
sheets, Internet sources, or other electronic media. What are the key concepts or principles that 
should be conveyed in a message? What is the individual to do about behavior as well as intent? 
Much important research can be done around these questions. 
V. Administrative Controls - Environmental Surveillance 
Exposure limits are an important aspect of environmental issues. In the military, there are at least 
three major environments: the theater of war, operations other than warfare, and in garrison. In a 
conflict situation, protection might not be as absolute as it is in the civilian environment. It must 
be considered that individuals are actually living where they are working and the usual exposure 
limits of eight hours a day, forty hours a week, are no longer germane. The real limits are twenty-
four hours a day, 168 hours a week. Distinguishing non-combat from combat effects also 
requires an understanding of the limits of the instrumentation and a knowledge of factors 
influencing false positives, false negatives, sensitivity, and specificity. Prioritization of high 
hazards and low hazards is essential. Chemical and biological warfare exposures would usually be 
of higher concern than exposure to industrial chemicals. However, in certain theaters, there may 
be exposure to large quantities of toxic industrial chemicals. Research is needed to: 
1)	 Develop enhanced instrumentation for nuclear, biological, chemical, and environmental 
exposure assessment. 
2)	 Establish exposure limits that take into account the multiple operating environments. 
3)	 Characterize the environment of deployment. 
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VI. Administrative Controls - Medical Surveillance and Biomonitoring 
A current problem of considerable magnitude is the difficulty of linking medical information and 
tracking an individual’s health records from civilian life, into the military arena, and back into 
civilian life. Without such systems, long-term follow-up and retrospective examination of health 
records remain almost impossible tasks. A major point that must be considered is privacy of the 
data, and there should be an organized effort to attend to this issue. First, a way of managing the 
data could be developed that would allow both DoD and VA use of information for various 
purposes, while simultaneously preserving the privacy of the data. A second area of concern is 
that if there is not adequate privacy of the data, the validity of the self-report data will be seriously 
compromised. Critical research is needed to: 
1) Develop a data gathering tool that spans the life of the service member, that accompanies 
the person from DoD to VA to civilian life, and that links both exposure information and 
health outcomes. 
2) Validate self-reported environmental exposures. 
3) Develop an effective prospective surveillance system for multiple endpoints. 
4) Develop methods for surveillance of low level exposures. 
5) Develop methods for archiving biological specimens. 
Current surveillance instruments and questionnaires do not employ language that can 
unequivocally avoid ambiguous answers. For example, a question such as “Were you ever . . .” 
does not help retrospectively to put together an exposure assessment. Following military 
personnel forward into future life, presumably civilian life, is problematic. Low-level exposure 
assessment also presents difficulties. There is need to define what low-level exposure is, but the 
definition would depend on the toxicant under scrutiny. If specimens were stored and retrievable, 
making comparisons for end points identified in future research would be possible. Such 
specimen archiving is being done with high risk civilian occupation groups and with other groups 
that are at high-risk for developing certain types of diseases. 
VII. Work Practices 
Consideration must be given to safety and health management in civilian life, often termed 
comprehensive safety and health plans, which incorporate built-in audit or outcome assessment 
components. More reservists and National Guard members were used during the Gulf War than 
in previous conflicts. A key work practice issue is how such part-time military service members 
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are integrated with full-time service members into functional units. Should reservists and National 
Guard members be organized alongside full-time personnel, or should there be separate units of 
full-time and part-time military personnel? This work organization issue might be a focus for 
future research efforts. Research strategies can be developed to: 
1) Evaluate existing health hazard protocols and develop metrics to compare work practice 
risk. 
2) Explore the impact of varied work organization structures on negative health outcomes. 
3) Develop audit and investigation systems to insure implementation of management control 
efficiencies. 
VIII. Personal Protective Equipment (PPE) 
DoD should more aggressively utilize existing expertise in the civilian sector for such items as 
chemical protective clothing and respiratory protection. Research needs should focus on projects 
to: 
1) Design protective clothing that is durable, viable, and ergonomically flexible. 
2) Develop and validate data/standards for PPE compliance that strive to adhere to the 
existing regulatory standards, such as those of the Occupational Safety and Health 
Administration and the Mine Safety and Health Administration. 
Clearly, in the warfare arena, there are situations with extenuating circumstances that would 
preclude full adherence to these standards. However, there remains much opportunity in the near 
term to implement the same types of classical, good occupational health practices regarding PPE 
as exist in the civilian sector. 
High Priority Recommendations 
In the short-term, prevention research approaches can be initiated immediately in the following 
five areas, as much background data and information already exist. 
1) Assessment of what has already been done since 1991. 
2) Comprehensive safety and health management program. 
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3) Metrics for implementation and effectiveness. 
4) Personal protective equipment. 
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Chapter 6 
Discussion 
An intensive research effort to address Gulf War veterans’ health concerns has been mounted by 
federal agencies and non-governmental scientists. As of 1999, there have been 145 federally-
funded research projects on Gulf War veterans’ illnesses with a cumulative expenditure of $133.5 
million for research from FY94 through FY99 (6). These projects represent a broad spectrum of 
research efforts, ranging from small pilot studies to large-scale epidemiology studies addressing 
mechanistic, clinical, and epidemiological issues. Similar efforts have been initiated in other 
coalition countries, most notably in the United Kingdom and Canada. In addition, numerous 
review panels and expert committees have evaluated the available data on Gulf War veterans’ 
illnesses (7-10). Despite these extensive research and review efforts, many questions remain 
regarding the health impact of the Gulf War and the health of troops in future deployments. 
The purpose of the Centers for Disease Control and Prevention (CDC) sponsored conference, The 
Health Impact of Chemical Exposures During the Gulf War: A Research Planning Conference, 
was to bring together scientists, veterans and their representatives, patient advocates, and other 
interested parties to obtain broad public input on the development of future research priorities for 
addressing the relationship between chemical exposures during the Gulf War and illnesses 
affecting Gulf War veterans. Veterans have often felt left out of the research planning process 
and thus have become mistrustful of government efforts to address their health concerns. This 
conference highlights the usefulness of establishing an ongoing dialog among veterans, scientists, 
and government officials. 
The recommendations developed at this conference include suggestions for research across many 
different areas of concern to Gulf War veterans and reflect the combined input of the veteran, 
medical scientist, and patient advocate participants. While some of the recommendations could be 
implemented in the short-term, many of the recommendations reflect long-term goals requiring 
significant restructuring of current systems and are unlikely to be easily implemented, especially in 
the time frame requested by Gulf War veterans. Some recommendations reflect initiatives that 
have already been instituted by federal agencies responsible for the care of veterans. Still other 
recommendations may not be feasible. For example, a study of Iraqi soldiers conducted or 
supported by U.S. researchers or the federal government may not be possible due to prohibitions 
on travel and the transfer of funds to Iraq. It will be necessary to compare these research 
proposals with previous recommendations made by numerous review groups and with ongoing 
research to determine areas that are newly identified. It should also be noted that these 
recommendations have not been endorsed by the veteran and scientific community as a whole nor 
by the federal government. The purpose of this report is to document the deliberations of the 
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the future direction of Gulf War illnesses research. 
One clear recommendation from the conference is the need to involve veterans in the process of 
planning and implementing research. Congress has also emphasized the need for veterans’ input. 
Section 104 of Public Law 105-368 directed the Secretary of Veterans Affairs to establish a 
public advisory committee on Gulf War veterans’ illnesses research.  In response to this 
legislation, the Department of Veterans Affairs (VA) is in the process of forming the Research 
Advisory Committee on Gulf War Veterans’ Illnesses which will be composed of veterans, 
veterans’ representatives, and non-governmental scientists.  This committee will provide advice 
and make recommendations to the VA Chief Research and Development Officer in his capacity as 
Chairperson of the interagency Research Working Group (RWG) of the Persian Gulf Veterans 
Coordinating Board, to the Under Secretary for Health, and to the Secretary for Veterans Affairs 
on research relating to Gulf War veterans’ illnesses.  Members for the advisory group will be 
selected based on their ability to represent the broad health concerns of Gulf War veterans or to 
provide scientific expertise in the areas of basic biomedical research, epidemiologic research, 
clinical research, environmental and health research, and mental health and behavioral research. 
Conference participants also emphasized the need for a central body to coordinate and 
disseminate information. Suggestions were made that a data coordinating center be established 
and that it be modeled after the VA Cooperative Trials Network or the National Center for Post-
Traumatic Stress Disorder. Congress has also made recommendations in this area. The Defense 
Authorization Bill for Fiscal Year 1999 authorized the Secretary of Defense to establish a center 
for evaluation of the health of those serving in the armed forces upon return from deployment. In 
response to this legislation, the Department of Defense (DoD) has proposed to build upon 
existing programs to develop Centers for Deployment Health that will focus on force health 
protection, surveillance, clinical care, and research. 
Section 103 of Public Law 105-368 required the Secretary of Veterans Affairs to enter into an 
agreement with National Academy of Sciences’ Institute of Medicine (IOM) to develop a plan for 
the establishment of a VA national center on war-related illnesses and post-deployment health 
issues. In December1998, VA contracted with the IOM to assist in developing a plan for the 
establishment of this new center. In late 1999, the IOM Committee on a National Center on War-
Related Illnesses and Postdeployment Health Issues issued a report containing recommendations 
regarding the scope, focus, organizational structure, and funding for a National Center for 
Military Deployment Health Research (11). The committee specifically recommended that VA 
model the Deployment Health Center on VA’s Geriatric Research, Education, and Clinical 
Centers. The Center should focus on the health of active, reserve, and National Guard forces, and 
on veterans and their families. The IOM committee recommended that the Center establish a 
broad research addenda that addresses conditions that emerge both during and following 
deployment, including diagnosable conditions, medically unexplained symptoms, effects on health-
related quality of life, family impacts, and sequelae of combat injuries. Furthermore, the 
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committee recommended that the governing board for the Center should include representatives 
from VA, DoD, and HHS; representatives from the research community; and representatives from 
the community at large, including veterans and their families and the general public. 
Another point emphasized in this conference is the need for improved coordination and oversight 
of both Gulf War related research and future research on deployment health issues. This need for 
improved coordination has been previously noted by several oversight committees (10,12). To 
ensure that a coordinated research effort was developed to longitudinally follow up on the health 
status of Gulf War veterans, VA contracted with IOM to make recommendations regarding a 
systematic research approach to monitoring the ongoing health status of Gulf War veterans. The 
IOM Committee on Measuring the Health of Gulf War Veterans issued a report in September 
1999 containing suggestions for a research portfolio and core set of data elements that would 
facilitate linkages across studies (13). The IOM committee specifically recommended that 
population studies, health services research studies, and biomedical and clinical investigations be 
conducted and that all studies include measures reflecting core health concepts (death and 
duration of life, impairment, functional status, health perceptions, and health opportunity), and 
individual and environmental correlates of health. Furthermore, the committee recommended that 
a prospective cohort study of the population of Gulf War veterans be conducted in order to assess 
the health status of Gulf War veterans, changes in health over time, how Gulf War veterans health 
compares to other veteran and civilian groups, and the individual and environmental 
characteristics associated with health status. The IOM committee anticipated that this prospective 
cohort study would serve as the foundation for the entire portfolio of research activities. 
VA also contracted with IOM to conduct a review of the scientific and medical literature 
regarding adverse health effects associated with exposures experienced during the Gulf War. This 
committee will review information on a broad range of exposures and health outcomes and will 
make recommendations for additional scientific studies to resolve areas of continued scientific 
uncertainty related to the health consequences of Gulf War service. 
To address the issue of health outcomes in future deployments, a Presidential Review Directive 
(PRD) was issued directing the National Science and Technology Council to oversee the 
development of an interagency plan for minimizing or preventing post-conflict health concerns in 
future deployments. PRD-5, Planning for Health Preparedness for and Readjustment of the 
Military, Veterans, and Their Families after Future Deployments, was released in November 
1998 (14). In this plan, specific recommendations are made regarding improving service 
members’ understanding of health risk information, improving medical and non-medical 
countermeasures, enhancing government collection of health and exposure data, improving 
linkages among health information systems, coordinating agency research activities, and 
improving delivery of health care services to veterans and their families. 
As recommended in PRD-5, VA, DoD and the Department of Health and Human Services (HHS) 
42
 
    Research Planning Conference Report 
will be co-chairing a permanent interagency coordinating board, the Military and Veterans’ Health 
Coordinating Board. This board will be responsible for ensuring coordination of federal clinical, 
research, and health risk communication efforts related to the health of military service members 
and veterans during and after deployments. The board will provide recommendations for 
deployment health and research activities, as well as for outreach and health risk communication 
efforts with veterans, the public, other federal government entities, military and veterans’ service 
organizations, health professionals, scientific professional societies, the media, and state, county, 
and local governments. 
Despite these current initiatives, additional research can add useful information on Gulf War 
veterans’ illnesses and assist in efforts to prevent illness among military personnel and their family 
members after future deployments. This report outlines recommendations for this future research 
based upon input by scientists, veterans, and other interested parties. In responding to these 
recommendations, funding agencies should be guided by sound scientific methodology and ethical 
principles established to protect research participants. 
Pathophysiology Recommendations: 
An overarching theme that arises from the recommendations of the pathophysiology workgroup is 
the synergy and benefits that result from interactive research among medical and basic research 
scientists and veterans. To maximize the chances for success, scientists must listen to the 
experiences of the veterans and attend to their needs. In order to enhance communication 
between veterans and scientists, the workgroup unanimously endorsed a recommendation for the 
establishment of a centralized research library and data repository that would collect research 
proposals and results and maintain them in a format that would be easily accessible and searchable 
electronically. 
The research agenda, whenever possible, should be interdisciplinary since the combined activity of 
both the basic and the clinical scientist is required in order to move from the bedside to the bench 
and from the bench to the bedside. The workgroup strongly emphasized that research should 
focus on unifying mechanisms that have the potential to explain the multi-system symptoms of 
Gulf War veterans. 
The workgroup recognized that the immediate needs of Gulf War veterans are important and 
pressing; however, the group also emphasized the value of investing a portion of available 
research funds in developing new methodologies through basic research. Chemical and biological 
weapons have emerged from being anecdotes in the history of human warfare to being pressing 
current environmental hazards in both military and civilian sectors. The importance of research on 
the mechanisms of action and the short- and long-term adverse health effects of acute, low-level 
and sub-lethal exposures has been recently recognized. 
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Of the areas identified by the participants as promising avenues for research, some of the research 
efforts already undertaken include the establishment of a number of epidemiologic studies, both in 
the U.S. and in the United Kingdom. In an effort to begin surveillance and determine prevalence 
information, the Naval Health Research Center in San Diego is establishing a birth defects 
registry. A five-year follow-up is underway of Army personnel exposed to chemical warfare 
agents at Khamisiyah. Much work is being done on the pharmacokinetics, pharmacodynamics, 
and central nervous system responses to pyridostigmine bromide in humans and animal models. A 
number of studies are focusing on effects of mixtures of chemicals: prophylactic drugs and 
pesticides with each other, with jet fuel, with sunlight, and with stress. Other studies seek to 
identify sites and pathophysiologic mechanisms of neurological damage specific to symptoms 
experienced by Gulf War veterans, both to provide a means for identifying patients needing 
treatment and to provide a basis for the development of new treatments. 
The need for research among coalition partners was strongly recommended by the 
pathophysiology workgroup. Some of this work has already been initiated. For example, an 
interagency effort between the Office of the Special Assistant on Gulf War Illnesses, the 
Uniformed Services University of the Health Sciences, the Naval Health Research Center, and 
CDC is currently in process. This study will examine health outcomes among members of the 
Saudi Arabian National Guard. 
As the level of knowledge of the pathophysiology and etiology of Gulf War veterans’ illnesses 
continues to increase, researchers hope that new insights will emerge which will lead to 
efficacious treatment for veterans, to a broader understanding of potentially similar conditions in 
civilian populations, and to effective prevention of disease in the future. 
Assessment and Diagnosis Recommendations: 
The issues involved in assessment and diagnosis include problems with case definition, proper 
identification of disease, and the nature of overlapping disorders which involve multiple organ 
systems. Primarily the symptoms are self reported and clinicians and researchers lack the proper 
measures to define unexplained illnesses affecting Gulf War veterans. The workgroup felt that the 
development of biomarkers to properly assess overlapping disorders, such as chronic fatigue 
syndrome (CFS), multiple chemical sensitivities (MCS), and fibromyalgia (FM), is extremely 
important so that a proper identification of disease can be made. The development of case 
definitions will be aided by the existence of specific biomarkers that are available in appropriate 
biological matrices, such as blood or urine. The proper application of unique biomarkers in the 
investigation of disorders such as the illnesses in Gulf War veterans is valuable and will enhance 
the assessment, diagnosis, and treatment of these disorders. In order to study biomarkers of 
illness in Gulf War veterans, researchers may need to identify and characterize those parameters 
that have a biological half-life long enough to remain with the individual. Development of such 
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markers may have implications in many situations where the identification of a hazardous 
exposure comes years after the exposure occurred. Identification of versatile biomarkers will 
serve to protect troops in future deployments. 
CDC’s Division of Environmental Health Sciences in the National Center for Environmental 
Health has taken the lead in the development of biomarkers for environmental exposures. CDC 
scientists are developing technology that will rapidly assess a battery of 150 chemical agents in 
biological samples (blood and urine). This technology will allow for a determination of individual 
human exposure (including exposure level) to the targeted agents. Categories of chemical agents 
to be tested include chemical warfare agents, heavy metals, dioxins, and pesticides. This 
technology has the potential to be beneficial for both military and civilian populations because of 
its ability to rapidly address health concerns regarding environmental exposures. 
Recommendations from the workgroup also place a strong emphasis on the proper design of 
studies. Protocols relating to MCS, CFS, and FM must be designed so as to take into account the 
multifaceted nature of the disorders. There needs to be a critical evaluation of any study design in 
order to assure that proper measures are being used and that confounders are limited as much as 
possible. With respect to chemical interactions, care must be taken to study the appropriate 
combinations of chemicals using well-defined criteria so as to be able to draw reasonable 
conclusions from the study. 
Additional work should be done on developing a validated case definition. Problems have arisen 
in the past due, in part, to the lack of a proper case definition. While case definitions exist for 
research purposes, a validated case definition has not been developed. Although no universal case 
definition has been determined, many of the studies surrounding Gulf War illnesses have focused 
on the identification of a case definition and the assessment of the illnesses using a variety of 
approaches. Included in these are a number of studies which have put forth research case 
definitions which have been used in the evaluation of specific groups of veterans. These include 
studies of members of the Pennsylvania 193rd Air National Guard (15) and the 24th Reserve Naval 
Mobile Construction Battalion (16). 
There are several ongoing studies that are attempting to address the issue of case definition. CDC 
is funding the University of Medicine and Dentistry of New Jersey to investigate the stability of 
Gulf War veterans’ symptoms over time and to compare previously derived data-driven case 
definitions with existing definitions for chronic multi-system illnesses. The study will assess the 
generalizability of derived and existing case definitions in a new random sample of Gulf War 
veterans and will also assess the role of psychiatric conditions in the illnesses affecting Gulf War 
veterans. DoD is currently funding the University of Iowa School of Medicine to conduct a study 
on case validation of illnesses among Gulf War veterans from Iowa in order to compare rates of 
medically validated illnesses among deployed and non-deployed veterans. This study also 
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illness outcome. 
The workgroup made two general recommendations regarding the importance of continued 
declassification and dissemination of relevant scientific field investigations and clinical studies and 
the usefulness of adopting an interim assumption of service connection pending better 
characterization of Gulf War veterans’ illnesses.  These two recommendations highlight the 
interaction of public policy and science. Clearly, recommendations regarding service connection 
and declassification of documents reflect policy decisions rather than research issues. However, if 
possible, the best science should be brought to bear on this decision making. 
Treatment Recommendations: 
The deliberations of the treatment workgroup highlighted the need to move quickly to provide 
treatment options to Gulf War veterans. However, this need for swift action must be balanced 
with the equally important requirement that all treatment recommendations be based upon 
rigorous scientific methods with careful attention given to protecting the rights of patient 
participants. Anecdotal findings may provide fruitful avenues for innovative treatment 
approaches; however, these alternative treatment modalities will require scientific assessment to 
determine their efficacy prior to being implemented with large numbers of Gulf War veterans. 
This effort to provide effective treatment to Gulf War veterans will be hastened by examining and 
utilizing interventions that have been proven to be effective with other populations with similar 
overlapping conditions. This would include using interventions that have been proven to be 
effective for coping with pain, improving sleep quality, and minimizing memory deficits. For 
example, cognitive behavioral therapy techniques have been found to be effective in these areas 
(17-19). 
Significant progress in initiating treatment trials for Gulf War veterans was made in 1999. VA 
and DoD initiated two clinical treatment trials which should assist in the search for effective 
treatment regimens for Gulf War veterans. One study, the exercise/behavioral therapy trial, will 
focus on aerobic exercise and behavioral therapy to reduce the severity of chronic symptoms 
among Gulf War veterans who report pain, fatigue, and/or cognitive difficulties. More than 
1,300 veterans will be enrolled at VA and DoD medical centers across the U.S. The trial will 
assess whether exercise and cognitive behavioral therapy, separately or in combination, improve 
physical function. 
The second treatment trial will focus on assessing the effectiveness of antibiotic treatment in 
reducing Gulf War veterans’ chronic symptoms.  This will be a multi-site, 30-month, double-blind 
clinical trial of antibiotic treatment of symptomatic patients with positive findings for mycoplasma 
infection. The trial will identify 450 Gulf War veterans who are experiencing at least two of three 
chronic symptoms (fatigue, musculoskeletal pain, and neurocognitive dysfunction) and who test 
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positive for the microorganism Mycoplasma fermentans.  Subjects will be randomly assigned to 
12-month treatment with either 300 mg doxycycline per day or placebo. Outcome measures will 
include assessment of physical function, pain, fatigue, and cognitive functioning. 
Despite these current activities, there is considerable dissatisfaction among veterans regarding the 
availability of treatment options. The recommendations of the treatment workgroup represent a 
broad range of approaches which may offer promise for addressing the treatment needs of Gulf 
War veterans. The deliberations of the treatment workgroup emphasized the need for expanded 
clinical options, including clinical trials to examine the efficacy of alternative treatment approaches 
using sound scientific methods. The workgroup also emphasized the importance of expanding 
current outreach efforts to assess the needs of Gulf War veterans and to ensure that they and their 
health care providers are informed of the latest developments on Gulf War related research and 
clinical information. 
Prevention Recommendations: 
The prevention workgroup emphasized the importance of first assessing the steps that have been 
taken by DoD since the Gulf War to protect troop health. While a number of interventions are 
already in place, the workgroup noted that DoD and VA should significantly enhance their efforts 
to foster objective and thorough examination of the Gulf War experience (and subsequent 
deployments) in accord with widely accepted principles of public health. Lessons learned from 
the Gulf War (as well as from deployments in Bosnia, Haiti, and Somalia) include the need to 
correct deficiencies in record keeping, poor understanding of the relationship between exposure 
and response, and inadequate health risk communication. Valuable work and knowledge resides 
in the civilian sector. These sources have much to contribute to improvement of the overall 
health status of service members deployed in a wide range of environments. 
Several major efforts to protect the health of deployed U.S. forces have been initiated since the 
Gulf War. DoD has initiated a force health protection strategy to provide maximum health 
protection to service members throughout their military service. This strategy includes 
components to achieve a healthy and fit force, to enhance casualty prevention, and to improve 
casualty care and management. DoD, HHS, and VA jointly developed a strategic plan for 
improving the health of military veterans and their families. The Presidential Review Directive on 
Planning for Health Preparedness for and Readjustment of the Military, Veterans, and Their 
Families after Future Deployments (14) includes recommendations for improving deployment 
health, record keeping, research, and health risk communication. More recently, IOM issued a 
report on strategies to protect the health of deployed U.S. forces (20). This report contains 
detailed recommendations regarding medical surveillance, post-deployment reintegration, medical 
record keeping, risk communication, and strategies to address medically unexplained symptoms 
and to improve force health protection in reserve military components. 
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Clearly, considerable steps have been taken to develop strategies to prevent illness in future 
deployments. However, continued vigilance in needed to ensure that these “lessons learned” are 
put into practice in ways that are compatible with military service. Reliance upon basic public 
health principles and well-tested models and research tools, such as those currently used in 
occupational settings, will enhance our efforts to protect the health of military personnel 
throughout their life-cycle. 
Summary: 
HHS convened this conference in order to further the dialogue among government officials, 
scientists, and veterans on issues of upmost concern to the veterans of the Gulf War. Despite 
considerable government- and non-government-sponsored research to address the health impact 
of the Gulf War, we have yet to find the scientific basis for these veterans’ unexplained illnesses. 
This conference highlighted the importance of including veterans in the process of planning and 
implementing research. Veterans and scientists alike expressed that they found the process useful 
and that future similar efforts should be encouraged. 
The recommendations developed at this conference represent the deliberations of the workgroup 
participants and do not necessarily imply endorsement by the veteran or scientific community as a 
whole or by the federal government. The purpose of this report is to document the conference 
workgroup deliberations and to form the basis for further discussions regarding the direction of 
research into illnesses among Gulf War veterans. 
It is anticipated that this report will be of interest to a broad range of individuals and organizations 
and may encourage new research collaborations and exchanges. HHS has coordinated its Gulf 
War related research activities with those of the two principally responsible agencies, DoD and 
VA, through the RWG of the Persian Gulf Veterans Coordinating Board. It is through the RWG 
that the federal research agenda is developed and coordinated. Recommendations for new 
research will need to be considered in light of the existing research portfolio of the RWG. 
48
 
    Research Planning Conference Report 
References 
(1)	 Department of Health and Human Services. Report to Congress on Research on Multiple 
Chemical Exposures and Veterans with Gulf War Illnesses, 1998. 
(2)	 Congressional Record. House Report 105-205, page 129/130, 1997. 
(3)	 McClure P, Richards W, Ingerman L, Llados F, Neal, M. Background Document on Gulf 
War-Related Research for the Health Impact of Chemical Exposures During the Gulf War: 
A Research Planning Conference, 1999. 
(4)	 National Institutes of Health. Environmental Health Perspectives Supplements: Chemical 
Sensitivity (Volume 105, Number 2), 1997. 
(5)	 Research Working Group of the Persian Gulf Veterans Coordinating Board. Annual Report 
to Congress: Federally Sponsored Research on Persian Gulf Veterans’ Illnesses for 1997. 
Department of Veterans Affairs, 1998. 
(6) 	 Research Working Group of the Persian Gulf Veterans Coordinating Board. Annual Report 
to Congress: Federally Sponsored Research on Gulf War Veterans’ Illnesses for 1998. 
Department of Veterans Affairs, 1999. 
(7) 	 National Institutes of Health Technology Assessment Workshop Panel. The Persian Gulf 
Experience and Health. JAMA 1994; 272(5): 391-396. 
(8) 	 Defense Science Board. Final Report: Defense Science Board Task Force on Persian Gulf 
War Health Effects. Washington, DC: Office of the Under Secretary of Defense for 
Acquisition and Technology, 1994. 
(9) 	 Committee to Review the Health Consequences of Service During the Persian Gulf War, 
Medical Follow-up Agency, Institute of Medicine. Health Consequences of Service During 
the Persian Gulf War: Recommendations for Research and Information Systems. 
Washington, DC: National Academy Press, 1996 
(10) Presidential Advisory Committee on Gulf War Veterans’ Illnesses.  	Final Report. 
Washington DC: U.S. Government Printing Office, 1996. 
49
 
    
 
Research Planning Conference Report 
(11) Institute of Medicine Committee on a National Center on War-related Illnesses and 
Postdeployment Health Issues. National Center for Military Deployment Health Research. 
Washington DC: National Academy Press, 1999. 
(12) Government Accounting Office. 	Gulf War Illnesses: Research, Clinical Monitoring, and 
Medical Surveillance. T-NSIAD-98-99, 1998. 
(13) Committee on Measuring the Health of Gulf War Veterans, Institute Of Medicine. 	Gulf 
War Veterans: Measuring Health. Washington DC: National Academy Press, 1999. 
(14) National Science and Technology Council. 	Presidential Review Directive 5: Planning for 
Health Preparedness for and Readjustment of the Military, Veterans, and their Families after 
Future Deployments, 1998. 
(15) Fukuda K, Nisenbaum R, Stewart G, Thompson WW, Robin L, Washko RM, Noah DL, et 
al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA
1998; 280: 981-988. 
(16) Haley RW, Kurt TL, Hom J. 	Is there a Gulf War syndrome? Searching for syndromes by 
factor analysis of symptoms. JAMA  1997; 277: 215-222. 
(17) Keefe FJ, Dunsmore J, Burnett R. 	Behavioral and cognitive-behavioral approaches to 
chronic pain: Recent advances and future direction.  J Consult Clin Psychol  1992; 60: 528­
536. 
(18) National Institutes of Health Technology Assessment Panel. 	Integration of behavior and 
relaxation approaches into the treatment of chronic pain and insomnia. JAMA  1996; 
274(4): 313-318. 
(19) Morley S, Eccleston C, Williams A. 	Systematic review and meta-analysis of randomized 
controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in 
adults, excluding headache. Pain  1999; 80(1-2): 1-13. 
(20) Institute of Medicine, Medical Follow-Up Agency. 	Strategies to Protect the Health of 
Deployed U.S. Forces: Medical Surveillance, Record Keeping, and Risk Reduction. 
Washington DC: National Academy Press, 1999. 
50
 





Mohamed Abou-Donia, PhD 
Professor, Dept. of Pharmacology 
Duke University Medical Center 
Durham, NC 
David P. Alberth, MEd 
Health Physicist 
US Army Center for Health Promotion 
and Preventive Medicine 
Aberdeen Proving Ground, MD 
Henry A. Anderson, MD 
Environmental/Occupational Epidemiologist 
Division of Public Health 




Unified Veterans of America 
Dunn, NC 
Happy Araneta, PhD, MPH 
Epidemiologist 
Emerging Illness Research Team 
Naval Health Research Center 
San Diego, CA 
Wes Ashford, MD, PhD 
Associate Professor and Vice Chair 
Univ. of Kentucky/VAMC of Lexington 
Lexington, KY 
David Ashley, PhD 
Chief, Air Toxicants Branch 
National Center for Environmental Health 




Institute of Medicine 
Washington, DC 
Dewleen Baker, MD 
Director, Gulf War Screening Program 
VA Medical Center 
Cincinnati, OH 
James G. Barnes, CHP, BS 
Radiation Health Physicist 
Los Angeles, CA 
Drue H. Barrett, PhD 
Chief, Veterans’ Health Activity Working 
Group 
Division of Environmental Hazards and 
Health Effects 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Rebecca Bascom, MD, MPH 
Professor of Medicine 











William Baumzweiger, MD 
Physician 
Studio City, CA 
Iris R. Bell, MD, PhD 
Staff Physician 
Dept. of Psychiatry 
Tucson Veterans Affairs Medical Center 
Tucson, AZ 
Hendrik P. Benschop, DR 
Manager, Research Group Chemical
 Toxicology 
TNO Prins Maurits Laboratory 
Ryswyk, The Netherlands 
Jim Binns, BA 





Windsor Locks, CT 
Donald W. Black, MD 
Professor of Psychiatry 
Univ. of Iowa College of Medicine 
Iowa City, IA 






Persian Gulf Outreach Committee 
Oklahoma State Health Department 
Oklahoma City, OK 
LT. COL. Philip Bolton 
Medical Advisor 
Gulf Veterans Illness Unit 
Ministry of Defence 
Whitehall, London UK 
Christopher J. Borgert, PhD 
President 
Applied Pharmacology & Toxicology 
Alachua, FL 
Keith Boylan, BA 
Persian Gulf Outreach Coordinator 
Swords to Plowshares 
San Francisco, CA 
Lawrence A. Bradley, PhD 
Professor of Medicine 
Div. of Chemical Immunology and 
Rheumatology 
University of Alabama at Birmingham 
Birmingham, AL 
Kelly Brix, MD, MPH 
Physician 
Office of the Special Assistant
 for Gulf War Illness 








    Research Planning Conference Report 
Stuart M. Brooks, MD 
Prof., Colleges of Medicine and Public 
Health 
Dir., Sunshine Education and Research 
Center 
Department of Environmental and
 Occupational Health 
College of Public Health 
University of South Florida 
Tampa, FL 




Gulf War Veterans of NC 
Gastonia, NC 
Ivy D. Bryant, MSW 
Gulf War Coordinator 
Hines VA Hospital 
Hines, IL 
Vinh Cam, PhD 
Presidential Special Overnight Board
 for DoD Investigations of Gulf War
 Chemical and Biological Incidents 
Greenwich, CT 
Stan Caress, PhD 
Associate Professor 
State University of West Georgia 
Winston, GA 
Howard S. Carry, PhD, MA, BA 
Professor 
Georgia State University 
Atlanta, GA 
David Carter 
Chairman, OK Agent Orange Foundation 
Board of Directors, Admiral Zumwalt’s 
Agent Orange Coordinating Council 




US Army CHPPM 
Aberdeen Proving Ground, MD 
Matthew Chute 
CFIDS Association 
St. Petersburg, FL 
Dan Clauw, MD 
Assoc. Professor of Medicine and 
Orthopaedics 
Chief, Division of Rheumatology, 
Immunology and Allergy 
Georgetown University 
Washington, DC 
Irving Cohen, MD 
Physician 
Topeka, KS 
Kevin L. Colbert 
Gardere, Wynne, Sewell & Riggs, L.L.P. 
Houston, TX 
Jacqueline Colson, BS, JD 
Burnsville, NC 
James Cone, MD, MPH 
Acting Chief, Occupational Health Branch 




    Research Planning Conference Report 
David N. Cowan, PhD, MPH 
Senior Scientist 
Exponent Health Group 
Landover, MD 
Michael Crutcher, MD 
Epidemiologist 
Oklahoma State Health Department 
Oklahoma City, OK 
Kristina Dahl, MD 
Clinical Instructor 
University of Medicine 
and Dentistry of New Jersey 
East Orange, NJ 
COL. David Danley, PhD 
Commander 
US Army Center for Envir. Health Research 
Fort Detrick, MD 
Janet Dauble, BS 
Executive Director 
Share, Care, & Prayer, Inc. 
Frazier Park, CA 
Miriam Davis, PhD 
Consultant 
Institutes of Medicine 
Silver Spring, MD 
Peggy L. Davis 
Atlanta, GA 
COL. Eric G. Daxon, PhD, MS, CHP 
Radiation Hygiene Staff Officer 
US Army Medical Command 
Fort Sam Houston, TX 
Donna J. Dean, PhD 
Senior Advisor to the Deputy Director 
National Institutes of Health 
Bethesda, MD 
Phyllis Deel, MSN 
Family Nurse Practitioner 
James H. Quillen VA Medical Center 
Mountain Home, TN 
Gwen Diehl 
Member 





Albert Donnay, MHS 
Director 
MCS Referral & Resources 
Baltimore, MD 
Richard Doty, PhD 
Director, Smell and Taste Center 
Professor of Otorhinolaryngology 




Member, Illinois Persian Gulf 
War Disease Commission 
Chicago, IL 




    Research Planning Conference Report 
Larry Edmonds, MSPH 
Acting Chief, State Services Branch 
Division of Birth Defects and Pediatric
 Genetics 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Donald Edwards 
Special Projects Coordinator 
for Congressman Sanders 
Burlington, VT 
Maggie Eklund, BSRT 
Promotional Director 
Desert Storm Justice Foundation 
Oklahoma City, OK 
Hossein Emami, MD 
Gulf War Registry Physician 








LTC. Charles C. Engel, Jr., MD, MPH 
Chief, Gulf War Health Center 
Walter Reed Army Medical Center 
Washington, DC 
James E. Estep, DVM, PhD 
Manager, Medical Research and Evaluation
 Facility 
Battelle Memorial Institute 
Columbus, OH 
Henry Falk, MD 
Director, Division of Environmental
 Hazards and Health Effects 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Robert G. Feldman, MD 
Professor and Chair 
Neurology and Pharmacology 
Boston University School of Medicine 
Boston, MA 
John R. Feussner, MD 
Chief Research and Development Officer 
Office of Research and Development 
Dept. of Veterans Affairs 
Washington, DC 
Nancy Fiedler, PhD 
Associate Professor 
Dept. of Environmental and Community
 Medicine 
UMDNJ-Robert Wood Johnson Medical
 School 
Piscataway, NJ 
Denise Figueroa, RN, BSN 
Hospice Northeast Florida 
Middleburg, FL 
Ron Figueroa, BA 
Personnel Manager 
Florida Dept. of Corrections 
Middleburg, FL 
Susan F. Franks, PhD 
Assistant Professor 
Univ. of North Texas Health Science Center 
Dept. of Psychiatry 
Ft. Worth, TX 
55
 
    Research Planning Conference Report 
John M. Frazier, PhD 
Senior Scientist 
Air Force Research Laboratory 
Wright-Patterson AFB, OH 
Mike Gaboriault 
Gulf War Veterans of Georgia 
Columbus, GA 
COL. Gary D. Gackstetter, DVM, MPH,
PhD 
Assistant Professor and Deputy Director 
Division of Epidemiology and Biostatistics 
Department of Preventive Medicine and
Biometrics 




Gulf War Veterans of Georgia 
Marietta, GA 
Diane Gates-Dulka 
National Public Affairs Officer 
ODSSA 
Windsor Locks, CT 
Timothy Gerrity, PhD 
Special Assistant to the Chief
Research and Development Officer 
Dept. of Veterans Affairs 
Washington, DC 
Linda Godfrey, BSN 
Registered Nurse 
VA Medical Center 
Lexington, KY 
Beatrice Golomb, MD, PhD 
Health Consultant 
RAND 
Santa Monica, CA 
Victor Gordan, MD 
Staff Physician 
Outpatient Service 
Manchester VA Medical Center 
Manchester, NH 
Arnold Bernard Gorin, MD 
Director, National Referral Center
 for Gulf War Veterans 
Dept. of Veterans Affairs 
Baylor College of Medicine 
Houston, TX 
Richard Graveling, PhD 
Head, Dept. of Ergonomics 
Institute of Occupational Medicine 
Edinburgh, Scotland 
J. Terrence Gray 
Director 




Uranium Medical Project 
Kuckville, NY 
Gareth Griffiths, BSc, PhD 
Principal Scientist 
Biomedical Sciences/DERA 
Sousbury, Wiltshire, UK 
56
 
    Research Planning Conference Report 
Mike Groutt 
Agency for Toxic Substances
 and Disease Registry 
Atlanta, GA 
Paul Gruendler, BAEd 
Member, RSES 
Rising Fawn, GA 
Fletcher F. Hahn, DVM, PhD 
Lovelace Respiratory Research Institute 
Albuquerque, NM 
Robert Hahn, PhD, MPH 
Epidemiologist 
House Veterans’ Affairs Committee 
US House of Representatives 
Bethesda, MD 
David D. Haines 
Univ. of Connecticut Medical School 
Dept. of Pathology 
Framington, CT 
Robert G. Haines, PhD, BCE 
President, Aurum Co. 
Orange Park, FL 
Robert Haley, MD, FACE, FACP 
Director, Division of Epidemiology 
Department of Internal Medicine 





North Shore Veterans Counseling Services 
Lynn, MA 
Kathleen Hannan, MD 
Orlando, FL 
Anthony Hardie 
Constituent Liaison, Veterans’ Affairs 
Office of US Representative Tammy
 Baldwin 
2nd District of Wisconsin 
Madison, WI 
Lloyd Hastings, PhD 
Smell and Taste Center 
University of Pennsylvania 
Philadelphia, PA 
Helen Havard, BSc 
Ministry of Defence 
Whitehall, London, UK 
Gail Hayes 
Sr. Public Affairs Specialist 
Division of Media Relations 
Centers for Disease Control and Prevention 
Atlanta, GA 
Kristin J. Heaton, MS 
Research Analyst 
Boston Environmental Hazards Center 
Boston, MA 




US Army Center for Health Promotion 
and Preventive Medicine 
Aberdeen Proving Ground, MD 
57
 
    Research Planning Conference Report 
Lee Hilborne, MD, MPH 
Associate Professor 
RAND & UCLA School of Medicine 
Los Angeles, CA 
Rick Hirst 
Training and Quality Control Specialist 
Veterans of Foreign War-Washington Office 
Washington, DC 
Curt Hofer, MD 
CCEP Evaluator 
Tripler Army Medical Center 
Honolulu, HI 
Arthur S. Hume, PhD 
Professor 
Univ.of Mississippi Medical Center 
Jackson, MS 39216 
Erick K. Ishii, PhD, MPH 
Staff Medical Analyst 
Presidential Special Oversight Board 
Arlington, VA 
Leslie Israel, DO, MPH 
Medical Director 
Assistant Clinical Professor 
Dept. of Medicine 
University of California, San Francisco 
San Francisco, CA 
Mattie Jackson 
Grants Management Specialist 
Procurement and Grants Office 
Centers for Disease Control and Prevention 
Atlanta, GA 
Richard Jackson, MD, MPH 
Director 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Hikmet Jamil, MD, PhD 
School of Medicine 
Wayne State University 
Detroit, MI 
Dan E. Jones, PhD 
Director, Post-Traumatic Stress Recovery 
Oklahoma City VA Medical Center 
Oklahoma City, OK 
Debbie Judd, RN, MPA/HSA 
President 
N. California Association of Gulf War
 Veterans 
Valley Springs, CA 
David J. Junces, BFA, JD 
Marshfield, WI 
V. F. Kalasinsky, PhD 
Chief, Division of Environmental
 Toxicology 
Armed Forces Institute of Pathology 
Washington, DC 
Han K. Kang, DrPH 
Director 
Environmental Epidemiology Service 




    Research Planning Conference Report 
Sam Keith, MS 
Environmental Health Scientist 
Division of Toxicology 
Agency for Toxic Substances and Disease 
Registry 
Atlanta, GA 
Debra Kelley, MEd 
Gulf War Info. Section Specialist 
Secretary of Air Force 
Maxwell AFB, AL 
Alison Kelly 
Deputy Associate Director 
Office of Planning, Evaluation and
 Legislation 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Adrian Kent, BA 
Pre-Doctoral Trainee 
Oklahoma State Dept. of Health 
Oklahoma City, OK 
Edwin Kilbourne, MD 
Senior Medical Officer 
Office of the Director 
Div. of Environmental Hazards and Health
 Effects 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
CAPT Michael Kilpatrick, MD 
Director, Medical Outreach and Information 
Office of the Special Assistant for Gulf War
 Illnesses 
Dept. of Defense 
Falls Church, VA 
Howard M. Kipen, MD, MPH 
Associate Professor 
Director, Division of Occupational Health 
Environmental and Occupational Health
 Sciences Institute 
UMDNJ-Robert Wood Johnson Medical
 School 
Piscataway, NJ 
Ruth Kirschstein, MD 
Deputy Director 
National Institutes of Health 
Bethesda, MD 
Rebecca J. Klemm, PhD 
President 
Klemm Analysis Group 
Washington, DC 
Ginny Kloth 
Chemical Injury Information Network 
Blue Ridge, GA 
Jerry Kloth 
Chemical Injury Information Network 
Blue Ridge, GA 
Adam Korenyi-Both 
Undergraduate 
University of Dayton 
Centerville, OH 
COL. Andras Korenyi-Both 
Comprehensive Medical Network 
Old Forge, PA 
George Korenyi-Both, BS, MEd 






    Research Planning Conference Report 
Micheal Krueger, MSN 
Family Nurse Practitioner 
Gulf War Treatment 
VA Medical Center 
Cincinnati, OH 
Charles Lamielle 
Board of Directors 
National Center for Environmental Health




National Center for Environmental Health
 Strategies, Inc. 
Voorhees, NJ 




Harry Lee, MD 
Professor 
Ministry of Defence 
Whitehall, London, UK 
Damacio Lopez, BS 
Research Director 
Re-Visioning New Mexico 
Bernalillo, NM 
C. Kirt Love 
Signing My Life Away 
Copperas Cove, TX 
Mark Lowery, BS 
Preventive Medical Consultant 
Oklahoma State Dept. of Health 
Oklahoma City, OK 
James W. Loyd, DC 
Loyd Chiropractic Center 
Buffalo, WY 
James B. Lucot, PhD 
Associate Professor 
Wright State University 
Dept. of Pharmacology 
Dayton, OH 
Max Lum, EdD, MPA 
Associate Director for Health
 Communication 
Nat'l Institute of Occupational Safety &
 Health 
Washington, DC 
Linda M. Lund, PhD 
Gulf War Research Study Coordinator 
VA Medical Center 
Cleveland, OH 
Ann M. Maddrey, PhD 
Assistant Professor 
Dir. of Biobehavioral Programs 









    Research Planning Conference Report 
Greg Mason 
3rd Army 
Ft. McPherson, GA 
CAPT Peter Mazzella 
Director, Office of Military Liaison 
  and Veterans’ Affairs 
Office of Public Health & Science 
Department of Health and Human Services 
Washington, DC 
Linda McCauley, PhD 
Associate Professor 
Oregon Health Sciences University 
Center for Research on Occupational 
and Environmental Toxicology 
Portland, OR 
L. A. McClure 
Alaska Gulf War Syndrome 
Referrals Coordinator 
Eagle River, AK 
Peter McClure, PhD, DABT 
Syracuse Research Corp. 
N. Syracuse, NY 
Melissa McDiarmid, MD, MPH 
Assistant Professor of Medicine 
University of Maryland 
Director, VA Depleted Uranium Program
 Occupational Health Project 
Baltimore, MD 
Stephen McFadden, MS 
Independent Research Advocates 
Dallas, TX 
Ruth G. McGill, MD 
Psychiatrist 
San Angelo, TX 
CDR Patrick McNeilly 
Deputy Director 
Office of Military Liaison and Veterans’
 Affairs 
Office of Public Health & Science 
Dept. of Health and Human Services 
Washington, DC 
Irvine G. McQuarrie, MD, PhD 
Director, Gulf War Clinic 
VA Medical Center 
Cleveland, OH 
William Meggs, MD, PhD 
Associate Professor of Emergency Medicine 
Vice Chair for Clinical Affairs 
Chief, Division of Toxicology 
Department of Emergency Medicine 
East Carolina University School of Medicine 
Greenville, NC 
Suzanne Migdall, BS 
Co-Author, “Sandstorm: American
   Women in the Gulf War” 
Desert Storm Justice Foundation 
Fort Lauderdale, FL 
Claudia S. Miller, MD, MS 
Associate Professor 
Dept. of Family Practice 
University of Texas Health Science Center 
San Antonio, TX 
Joseph G. Miller 
North Carolina National Guard 




Los Angeles, CA 
61
 
    Research Planning Conference Report 
Jim Milster 
Information Security Specialist 
US Air Force 
Maxwell AFB, AL 
F. L. Mitchell, DO 
Atlanta, GA 
Debra Moodie, ADN 
Secretary 
New England Persian Gulf Veterans, Inc. 
Craftsbury, VT 
Fabian Moodie 
New England Persian Gulf Veterans, Inc. 
Craftsbury, VT 
David H. Moore, DVM, PhD 
Battelle Memorial Institute 
Bel Air, MD 
William E. Morton, MD, DrPH 




Rollins School of Public Health 
Decatur, GA 
Moiz Mumtaz, PhD 
Science Advisor 
Research Implementation Branch 
Division of Toxicology 
Agency for Toxic Substances & Disease
 Registry 
Atlanta, GA 
Edward A. Murillo 
Seneca, SC 
Tammy S. Murillo 
Seneca, SC 
Ronald M. Murray 
President, Gulf War Veterans of GA 





Benjamin Natelson, MD 
Professor, Dept. of Neuroscience 
New Jersey Medical School 
East Orange, NJ 
Michael Naylon 
Presidential Special Oversight Board 
Washington, DC 
Michael Neal, PhD 
Syracuse Research Corp. 
N. Syracuse, NY 
R. Neutra, MD, DrPH 
Chief, Division of Environmental 
and Occupational Disease Control 








    Research Planning Conference Report 
Sheila Newton, PhD 
Director of Policy, Planning and Evaluation 
Office of the Director 
Nat'l Institute of Environmental Health
 Sciences 
National Institutes of Health 
Research Triangle Park, NC 
Denise Nichols, MAJ., USAFR (Ret), MS 
Vice Chair, National Vietnam and Gulf War
 Veterans Coalition 
President and Founder, Desert Storm
 Veterans of the Rocky Mountains 
Wheat Ridge, CO 
Deborah O. Norris, PhD 
Neurotoxicologist 
US Environmental Protection Agency 




Co-Author, “Sandstorm: American 
   Women in the Gulf War” 
Oklahoma City, OK 
Jacqueline Olsen 
Director, Gulf War Veterans of 
Long Island/VetCenter OnLine 
Member, ODSSA 
E. Patchogue, NY 
Carl T. Olson, DVM, PhD 
Research Leader 
Battelle Memorial Institute 
Columbus, OH 
Beatriz Orduna-Salisbury, MD, MPH, 
FACPM 
Staff Physician 
Occupational, Environmental, and 
Administrative Medicine 
Albuquerque VA Medical Center 
Albuquerque, NM 
Alice R. Osherman, MPA 
NCCI 
Bradenton, FL 
Neil S. Otchin, MD 
Program Chief, Clinical Medicine 
VA Central Office 
Washington, DC 
John E. Ottenweller, PhD 
Research Physiologist 
Dept. of Veterans Affairs 
East Orange, NJ 
David Ozonoff, MD, MPH 
Chair, Dept. of Environmental Health 
Boston Univ. School of Public Health 






Carole Palumbo, PhD 
Research Associate 
Boston VA Medical Center 




    Research Planning Conference Report 
Mark A. Patterson 
Chairman, Illinois Persian Gulf War
 Disease Commission 
Springfield, IL 
Mary Paxton, PhD 
Senior Toxicologist 
Klemm Analysis Group 
Washington, DC 
Arnold Peckerman, PhD 
Asst. Professor, Dept. of Neurosciences 
Univ. of Medicine and Dentistry of NJ 
Director, Psychophysiology Laboratory 
Gulf War Research Center 
East Orange VA Medical Center 
East Orange, NJ 
Darryl Peek 
Weapons Armament Specialist 
Gulf War Veteran 
Clarkston, GA 
Frederick Petty, PhD, MD 
Professor 









James Pirkle, MD, PhD 
Assistant Director for Science 
Division of Environmental Health
 Laboratory Sciences 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
Gary B. Pitts, JD 
Pitts & Associates 
Houston, TX 
Lawrence A. Plumlee, MD 
Co-President 





United Veterans of America 
Dunn, NC 
Marilyn Poe 




Rural Alliance for Military Accountability 
Reno, NV 
Oona M. Powell, MA 
Senior Media Relations Specialist 
National Center for Environmental Health 




    Research Planning Conference Report 
Susan Proctor, DSc 
Research Associate Professor
 in Environmental Health 
School of Public Health 
Boston University 
Assistant Director, Boston Environmental
 Hazards Center 
Boston, MA 
Matthew L. Puglisi 
Assistant Director, Gulf War Programs 
The American Legion 
Washington, DC 
Alan Rabson, MD 
Deputy Director 
National Cancer Institute 








William Rea, MD, FACS 
Director, Environmental Health Center­
Dallas 
Dallas, TX 
Philip O. Renzullo, PhD, MPH 
Senior Program Officer 
Institute of Medicine/National Academy of
 Sciences 
Washington, DC 
Cindy Lynn Richard, CIH 




Glenn D. Ritchie, PhD 
Senior Scientist 
Naval Health Research Center 
Wright-Patterson AFB, OH 
Douglas Rokke, PhD 
Assistant Professor 
Jacksonville State University 
Dept. of Physical and Earth Science 
Jacksonville, AL 
COL. Gilbert D. Roman 
Gulf War Veteran 
Lakewood, CO 
James A. Romano, Jr., PhD 
Deputy Commander 
US Army Medical Research Institute 
Institute of Chemical Defense 
Aberdeen Proving Ground, MD 
David E. Root, MD, MPH 
Medical Director 
Occupational Medical Group 
Sacramento, CA 
Noel Rose, MD, PhD 
Professor of Pathology, Molecular 
Microbiology and Immunology 




    Research Planning Conference Report 
John Rossi, III, PhD 
Office of the Chief of Naval Operations 
Arlington Navy Annex 
Washington, DC 
John Royle, BEd 
Ministry of Defence 
Whitehall, London, UK 
Harry Salem, PhD 
Chief Scientist 
Edgewood Biological Chemical Center 
Aberdeen Proving Ground, MD 
Don C. Salisbury, DO 
Gulf War Clinic Medical Director 
Albuquerque VA Medical Center 
Albuquerque, NM 
The Honorable Bernard Sanders 
US House of Representatives 
Washington, DC 
Karen Schmaling, PhD 
Associate Professor of Psychiatry
 and Behavioral Sciences 
University of Washington 
Seattle, WA 
Andrew Schmitt, MS 
Doctoral Candidate 
Univ. of Texas Southwestern Medical
 Center 
Mesquite, TX 
David Schwartz, MD, MPH 
Professor of Medicine 
Department of Internal Medicine 
University of Iowa College of Medicine 
Iowa City, IA 
COL. Ken Scott, MD 
Assistant Chief of Staff 
Health Support Operational Training Units 
Canadian Forces Medical Group ­
Headquarters 
Ottawa, Ontario, Canada 
Leah Scott, BSc 
Technical Manager 
Biomedical Sciences/ DERA 
Sousbury, Wiltshire, UK 
Shlomo Seidman, PhD 
Hebrew University of Jerusalem 
Dept. of Biological Chemistry 
Jerusalem, Israel 
CDR David W. Seipel, MA 
Naval War College 
Newport, RI 
Jay R. Shapiro, MD 
Director, CCEP, Gulf War Health Center 
Walter Reed Army Medical Center 
Washington, DC 
Krishna Sharma, MD 
Physician 
VA Medical Center 
Canandaigua, NY 
Michael Sharpe, MA, MB, MRCP 
Senior Lecturer in Psychological Medicine 
University of Edinburgh 







    Research Planning Conference Report 
Robert E. Sheridan, PhD 
Research Physiologist 
US Army Medical Research Institute
 of Chemical Defense 
Aberdeen Proving Ground, MD 
Rev. Dennis K. Shivers, BA, AA 
Municipal Court Clerk 
Decatur, GA 
Mamoru Shoji, MD 
Associate Professor of Medicine 
Emory University School of Medicine 
Atlanta, GA 
Edward Shorter, PhD 
Professor, History of Medicine 
Faculty of Medicine 
University of Toronto 
Toronto, Canada 
Thomas Shriver, PhD 
Professor of Sociology 




Operation Desert Shield/Storm Assn. 
Odessa, TX 
Leslie O. Simpson, MSc, PhD 
Red Blood Cell Research Trust 
Dunedin, New Zealand 
Chris Sinton, PhD 
Assistant Professor 
Univ. of Texas Southwestern Medical
 Center 
Dallas, TX 
David T. Smith 
State Commander 
Idaho Desert Storm Justice Foundation 
Lewiston, ID 
Debra K. Smith 
Vice President 
Idaho Desert Storm Justice Foundation 
Lewiston, ID 
LT COL Paul D. Smith, DO, MPH 
US Army Center for Health Promotion 
and Preventive Medicine 
Aberdeen Proving Ground, MD 
Richard Snodgrass 
Member 
Illinois Persian Gulf War Disease 
Commission 
Chapin, IL 
Anne Solomon, PhD, MA 
Research Fellow 
Department of Medicine 
Pennsylvania State College of Medicine 
Baltimore, MD 
Susan Solomon, PhD 
Senior Advisor, OBSSR 
National Institutes of Health 
Bethesda, MD 
Satu Somani, PhD 
Professor of Pharmacology and Toxicology 
Department of Pharmacology 




    Research Planning Conference Report 
Hermona Soreq, PhD 
Professor of Molecular Biology 
Head, Life Sciences Institute 
Hebrew University of Jerusalem
 Life Science Institute 
Jerusalem, Israel 
Barbara Sorg, PhD 
Assistant Professor 
Program in Neuroscience 
VCAPP Department 
Washington State University 
Pullman, WA 
Dalia M. Spektor, PhD 
RAND 
Santa Monica, CA 
Peter Spencer, PhD 
Professor and Director 
Center for Research on Occupational
 and Environmental Toxicology 
Oregon Health Sciences University 
Portland, OR 
Terry D. Spittler, PhD 
Senior Research Associate 
Center for the Environment and 





Office of US Senator Paul D. Coverdell 
Columbus, GA 








Director, Kansas Persian Gulf Veterans’

 Health Initiative 
Kansas Commission on Veterans’ Affairs 
Topeka, KS 
Alan M. Steinman, MD, MPH 
Presidential Oversight Board on Gulf War
 Illnesses 
Arlington, VA 
Linda Stokes, PhD 
Project Coordinator 
Gulf War Treatment Program 





William A. Suk, PhD, MPH 
Director, Office of Program Development 
National Institute of Envir. Health Sciences 
National Institutes of Health 
Durham, NC 
Paul Sullivan, BA 
Executive Director 
National Gulf War Resource Center 
Washington, DC 
G. Marie Swanson, PhD, MPH 
Professor of Family Practice 
Director, Cancer Center 
Michigan State University 
East Lansing, MI 
68
 
    Research Planning Conference Report 
Phillip Talboy, PHA 
Deputy Chief 
Veterans’ Health Activity Working Group 
Div. of Environmental Hazards and Health
 Effects 
National Center for Environmental Health 
Centers for Disease Control and Prevention 
Atlanta, GA 
William H. Taylor, PhD 
Staff Analyst 
Presidential Special Oversight Board 
Arlington, VA 
Stephen Thacker, MD 
Director 
Epidemiology Program Office 
Centers for Disease Control and Prevention 
Atlanta, GA 
Manisha Thakore, MD 
Neurologist 
Boston Univ. Medical Center 
VA Outpatient Clinic 
Boston, MA 
Diane Thomas, BA, MPA 
The Human Ecologist 
Decatur, GA 
LT COL Bob Thompson 
Preventive Medicine Action Officer 
Logistics Directorate - Joint Staff 
Medical Readiness Division 
The Joint Staff, Pentagon 
Washington, DC 
Thomas N. Tiedt, PhD 
Long Boat Key, FL 
Timothy Tinker, DrPH, MPH 
Chief, Communications and Research
 Branch 
Division of Health Education and Promotion 
Agency for Toxic Substances and Disease
 Registry 
Atlanta, GA 
James J. Tuite, III, MA 
Director, Interdisciplinary Science 
Chronic Illness Research Foundation 
Annandale, VA 
P. Utadej-Lakin, DO 
Physician, VA Medical Center 
Fayetteville, NC 
H.H.P.M. Van Helden, MD 
Research Group Pharmacology 
TNO Prins Maurits Laboratory 
The Netherlands 
Rajesh Venugopal, MPH 
Research Assistant 




National Legislative Director 
Disabled American Veterans 
Washington, DC 
Robert F. Vogt, PhD 
Research Chemist 
Clinical Biochemistry Branch 
Division of Environmental Health
 Laboratory Sciences 
National Center for Environmental Health 




    Research Planning Conference Report 
Richard Wadzinsky 
Veteran 




Lawrence M. Walsh 
State Senator 




Persian Gulf Veteran 
Stone Mountain, GA 
James Way, PhD 
Professor 
Texas A&M University 
College Station, TX 
Wendy Wendler, MBA 
National Board, Special Projects 
Desert Storm Justice Foundation 
Dallas, TX 
Ainsley Weston, PhD 
Team Leader, Molecular Carcinogenesis 
National Institutes for Occupational 
Safety and Health 
Centers for Disease Control and Prevention 
Morgantown, WV 
Gina Whitcomb 
Board Chair and Executive Director 




Desert Storm Justice Foundation 
Guthrie, OK 
Roberta White, PhD 
Director, Boston Environmental Hazards
 Center 
VA Medical Center 
Boston, MA 
Fred Willoughby 
Desert Storm Veteran 
Columbus, GA 
Ursula E. Willoughby 
Columbus, GA 
Barry Wilson, PhD 
Professor, Department of Animal Science
 and Department of Environmental
 Toxicology 
University of California, Davis 
Davis, CA 
Cynthia Wilson 
Executive Director and Chairman of the
 Board 
Chemical Injury Information Network and
 Environmental Access Research Network 
White Sulphur Springs, MT 
John Wilson 
President 
Chemical Injury Information Network and
 Environmental Access Research Network 
White Sulphur Springs, MT 
70
 
    Research Planning Conference Report 
Mitchell Wolfe, MD, MPH 
Epidemic Intelligence Service (EIS) Officer 
Surveillance and Programs Branch 
Division of Environmental Hazards and
 Health Effects 
Centers for Disease Control and Prevention 
Atlanta, GA 
Bob Wolfertz, MA 
LT. COL. Marine Corps (retired) 
Desert Storm Justice Foundation 
Bedford, NH 
Jessica Woods 
The Last Patrol 
St. Cloud, FL 
Michael Woods 
The Last Patrol 
St. Cloud, FL 
Jim Woodworth 
Administrative Director 
Occupational Medical Group 
Sacramento, CA 
Hong Zhang 







    Research Planning Conference Report 
Appendix B 
Members of the Conference Executive Planning Committee 
Drue H. Barrett, PhD (Chair) - Chief, Veterans’ Health Activity Working Group, Division of 
Environmental Hazards and Health Effects, National Center for Environmental Health, 
Centers for Disease Control and Prevention, Atlanta, Georgia 
Donna J. Dean, PhD - Senior Advisor to the Deputy Director, National Institutes of Health, 
Bethesda, Maryland 
CAPT Peter Mazzella - Director, Office of Military Liaison and Veterans Affairs, Office of 
Public Health and Science, Office of the Secretary, Department of Health and Human 
Services, Washington, DC 
CDR Patrick McNeilly - Deputy Director, Office of Military Liaison and Veterans Affairs, 
Office of Public Health and Science, Office of the Secretary, Department of Health and 
Human Services, Washington, DC 
Moiz Mumtaz, PhD - Science Advisor, Research Implementation Branch, Division of 
Toxicology, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia 
Sheila Newton, PhD - Director of Policy, Planning, and Evaluation, Office of the Director, 
National Institute of Environmental Health Sciences, National Institutes of Health, Research 
Triangle Park, North Carolina 
Phillip Talboy, PHA (Co-Chair) - Deputy Chief, Veterans’ Health Activity Working Group, 
Division of Environmental Hazards and Health Effects, National Center for Environmental 
Health, Centers for Disease Control and Prevention, Atlanta, Georgia 
72
 
    
  
Research Planning Conference Report 
Appendix C
 
Participants at July 21, 1998 Public Planning Meeting
 
Steven Adams, PHA - Meeting Moderator, Radiation Studies Branch, Division of Environmental 
Hazards and Health Effects, National Center for Environmental Health, Centers for Disease 
Control and Prevention, Atlanta, Georgia 
Drue H. Barrett, PhD - Chair, Executive Planning Committee, Chief, Veterans’ Health Activity 
Working Group, Division of Environmental Hazards and Health Effects, National Center for 
Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 
Kelley Brix, MD, MPH - Medical Staff, Office of the Special Assistant for Gulf War Illnesses, 
SRA, Inc., Falls Church, Virginia 
Stuart M. Brooks, MD - Professor, Colleges of Medicine and Public Health, Director, Sunshine 
Education and Research Center, Department of Environmental and Occupational Health, 
College of Public Health, University of South Florida, Tampa, Florida 
Roger Burns (Observer) - Editor, CFS-NEWS Newsletter, Washington, DC 
Janice Elaine Chambers, PhD - William L. Giles Distinguished Professor, Director, Center for 
Environmental Health Science, College of Veterinary Medicine, Mississippi State University, 
Mississippi State, Mississippi 
Donna J. Dean, PhD - Member, Executive Planning Committee, Senior Advisor to the Deputy 
Director, National Institutes of Health, Bethesda, Maryland 
Albert H. Donnay, MHS - Director, MCS Referral and Resources, Baltimore, Maryland 
Asaf Durakovic, MD, PhD, FACP - Professor, Georgetown University, Department of Nuclear 
Medicine, Washington, DC 
CDR David Edman (Observer) - Staff Director, Persian Gulf Veterans Coordinating Board, 
Interagency Support Office, Washington DC 
73
 
    Research Planning Conference Report 
COL Edward Elson - Medical Director, Persian Gulf Veterans Coordinating Board, Interagency 
Support Office, Washington DC 
Henry Falk, MD - Director, Division of Environmental Hazards and Health Effects, National 
Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, 
Georgia 
COL John Graham, MSc, MB, FFPHM - British Liaison Officer (Gulf Health), British 
Embassy, Washington DC 
Robert W. Haley, MD, FACE, FACP - Director, Division of Epidemiology, Department of 
Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 
Thomas Michael Hennessy, Jr. - RESCIND, Inc., Potomac, Maryland 
Anne Houser (Observer) - Office of Legislative Policy and Analysis, National Institutes of 
Health, Bethesda, Maryland 
CAPT G. Bryan Jones - Emergency Coordinator, Office of Emergency Preparedness, Region 3, 
Philadelphia, Pennsylvania 
Howard Kehrl, PhD - Medical Officer, Human Studies Division, U.S. Environmental Protection 
Agency, Human Studies Facility, Chapel Hill, North Carolina 
Howard Matthew Kipen, MD, MPH - Director, Division of Occupational Health, 
Environmental and Occupational Health Sciences Institute, UMDNJ-Robert Wood Johnson 
Medical School, Piscataway, New Jersey 
Andras L. Korenyi-Both, MD, PhD - Medical Director, Clinical Laboratories, Comprehensive 
Medical Network, Old Forge, Pennsylvania 
John Kraemer (Observer) - Senior Staff Analyst, Environmental Agents Service, Department of 
Veterans Affairs, Washington DC 
Chas. J. Lamielle (Observer) - National Center for Environmental Health Strategies, Inc, 
Voorhees, New Jersey 




    Research Planning Conference Report 
Brian J. Malkin, JD - Associate Director for Patents and Hearings, Office of Health Affairs, 
Office of the Commissioner, Food and Drug Administration, Rockville, Maryland 
CAPT Peter Mazzella - Member, Executive Planning Committee, Director, Office of Military 
Liaison and Veterans Affairs, Office of Public Health and Science, Office of the Secretary, 
Department of Health and Human Services, Washington DC 
John McNeill - Assistant Director for Veterans Benefits, Veterans of Foreign Wars, Washington, 
DC 
LCDR Patrick McNeilly - Member, Executive Planning Committee, Deputy Director, Office of 
Military Liaison and Veterans Affairs, Office of Public Health and Science, Office of the 
Secretary, Department of Health and Human Services, Washington DC 
William Joel Meggs, MD, PhD - Associate Professor of Emergency Medicine, Vice-Chair for 
Clinical Affairs, Chief, Division of Toxicology, Department of Emergency Medicine, East 
Carolina University School of Medicine, Greenville, North Carolina 
Claudia S. Miller, MD, MS - Associate Professor, Department of Family Practice, 
Environmental and Occupational Medicine, University of Texas Health Science Center. San 
Antonio, Texas 
John Muckelbauer (Observer) - Veterans of Foreign Wars, Washington DC 
Andre A. Muelenaer, Jr., MD - Director, Pediatric Pulmonology, Carilion Medical Center for 
Children at Community Hospital of Roanoke Valley, Roanoke, Virginia 
Moiz Mumtaz, PhD - Member, Executive Planning Committee, Science Advisor, Research 
Implementation Branch, Division of Toxicology, Agency for Toxic Substances and Disease 
Registry, Atlanta, Georgia 
Frances Murphy, MD - Director, Environmental Agents Service, Public Health and 
Environmental Hazards Office, Department of Veterans Affairs, Washington DC 
Sheila Newton, PhD - Member, Executive Planning Committee, Director of Policy, Planning, 
and Evaluation, Office of the Director, National Institute of Environmental Health Sciences, 
National Institutes of Health, Research Triangle Park, North Carolina 
75
 
    Research Planning Conference Report 
Deborah O. Norris, PhD - Neurotoxicologist, U.S. Environmental Protection Agency, Office of 
Pollution Prevention and Toxics, Washington, DC 
Lawrence A. Plumlee, MD - President, Chemical Sensitivity Disorders Association, 
Corresponding Secretary, National Coalition for the Chemically Injured, Bethesda, Maryland 
Matthew L. Puglisi - Assistant Director, Gulf War Programs, The American Legion, 
Washington, DC 
Cindy Lynn Richard, CIH - Senior Scientist, Environmental Sensitivities Research Institute, 
Columbia, Maryland 
Jonathan Silver Rutchik, MD, MPH - Medical Director, Division of Occupational and 
Environmental Neurology, Occupational Health and Rehabilitation, Inc., New York, New 
York 
Ronald Simon, JD - Simon and Associates, Washington, DC 
Lester Smith, PhD - Environmental Health Scientist, Executive Secretary, Interagency Work 
Group on Multiple Chemical Sensitivity, Office of the Assistant Administrator, Agency for 
Toxic Substances and Disease Registry, Atlanta, Georgia 
Terry D. Spittler, PhD - Associate Director, Cornell Analytical Laboratories, Senior Research 
Associate, NYS Agricultural Experiment Station, Cornell University, Geneva, New York 
William A. Suk, PhD - Chief, Chemical Exposures and Molecular Biology Branch, Division of 
Extramural Research and Training, National Institute of Environmental Health Sciences, 
National Institutes of Health, Research Triangle Park, North Carolina 
Paul Sullivan - Executive Director, National Gulf War Resource Center, Washington, DC 
Phillip Talboy, PHA - Co-Chair, Executive Planning Committee, Deputy Chief, Veterans’ 
Health Activity Working Group, Division of Environmental Hazards and Health Effects, 
National Center for Environmental Health, Centers for Disease Control and Prevention, 
Atlanta, Georgia 
James J. Tuite, III, MA - Director, Interdisciplinary Science, Chronic Illness Research 
Foundation, Annandale, Virginia 
76
 
    Research Planning Conference Report 
Robert F. Vogt, PhD - Research Chemist, Clinical Biochemistry Branch, Division of 
Environmental Health Laboratory Sciences, National Center for Environmental Health, Centers 
for Disease Control and Prevention, Atlanta, Georgia 
Note: Affiliations represent status at the time of the meeting. 
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Appendix D
 
The Health Impact of Chemical Exposures During the Gulf War: 





Day 1 (Sunday, February 28, 1999) 
8:00 - 8:10	 Welcome 
Richard Jackson, MD, MPH - Director, National Center for Environmental Health, Centers for
 Disease Control and Prevention 
Ruth Kirschstein, MD - Deputy Director, National Institutes of Health 
CAPT Peter Mazzella - Director, Office of Military Liaison and Veterans Affairs, Office of
 Public Health and Science, Department of Health and Human Services 
8:10- 8:30	 Opening Remarks 
The Honorable Bernard Sanders (I-Vermont) - U.S. House of Representatives 
Session I -	 Background: Gulf War Chemical Exposures and their Health Impact 
8:30 - 9:15	 Key Note Address - The Gulf War Experience: Current Findings and Future 
Directions 
G. Marie Swanson, PhD, MPH - Professor of Family Practice; Director, Cancer Center, 
Michigan State University 
9:15 - 10:00	 The Experience of Veterans (Panel Discussion) 
Moderator: Donald Edwards - Major General, United States Army (Ret.); Special Projects 
Coordinator for Congressman Bernard Sanders 
Anthony Hardie - President, Gulf War Veterans of Wisconsin; National Secretary, National Gulf 
War Resource Center 
Rick Hirst - Training and Quality Control Specialist, Veterans of Foreign Wars 
Debbie Judd, RN, MPA/HSA - President, Northern California Association of Gulf War Veterans; 
Board Member, National Gulf War Resource Center 
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L. A. McClure - Referrals Coordinator, Alaska Gulf War Syndrome 
Ronald Murray - President, Gulf War Veterans of Georgia; Board Member, National Gulf War 
Resource Center 
Denise Nichols, RN, MSN, MAJ, USAFR (Ret.) - Vice-Chair, National Vietnam and Gulf War 
Veterans Coalition; President and Founder, Desert Storm Veterans of the Rocky 
Mountains 
Matthew Puglisi - Assistant Director, Gulf War Programs, The American Legion 
Victor Silvester - International President, Operation Desert Shield/Desert Storm Association 
David Smith - State Commander, Idaho Desert Storm Justice Foundation 
Debra Smith - Vice President, National Gulf War Resource Center 
Joseph Violante - National Legislative Director, Disabled American Veterans 
Session II - Possible Health Outcomes of Low Level Chemical Exposures: 
What Do We Know From the Civilian Literature?
Moderator: David Schwartz, MD, MPH - Professor of Medicine, University of Iowa College of 
Medicine 
10:15 - 10:40 Health Effects of Chemicals on the Immune System 
Noel Rose, MD, PhD - Professor of Pathology and Professor of Molecular Microbiology and 
Immunology, Johns Hopkins University 
10:40 - 11:05 Health Effects of Chemicals on the Nervous System 
Peter Spencer, PhD, FRCPath - Professor and Director, Center for Research on Occupational 
and Environmental Toxicology, Oregon Health Sciences University 
11:05 - 11:30 Health Effects of Chemicals on the Pulmonary/Respiratory System 
Stuart Brooks, MD - Professor, Colleges of Medicine and Public Health; Director, Sunshine 
Education and Research Center, Department of Environmental and Occupational 
Health, College of Public Health, University of South Florida 
11:30 - 12:00 Panel Discussion 
Stuart Brooks, MD; Noel Rose, MD, PhD; David Schwartz, MD, MPH; Peter Spencer, PhD 
79
 
    
 
Research Planning Conference Report 
Session III -	 Multiple Chemical Sensitivity (MCS): Research and Clinical Findings among 
Gulf War Veterans and Civilian Populations 
Moderator: Claudia Miller, MD, MS - Associate Professor, Department of Family Practice, 
Environmental and Occupational Medicine, University of Texas Health Science Center 
1:30 - 2:15	 Research on MCS and Gulf War Veterans (Panel Report on Current Research) 
Iris Bell, MD, PhD - Staff Physician, Department of Psychiatry, Tucson Veterans Affairs 
Medical Center 
Donald Black, MD - Professor of Psychiatry, University of Iowa College of Medicine 
Daniel Clauw, MD - Associate Professor of Medicine and Orthopaedics, Chief, Division of 
Rheumatology, Immunology, and Allergy, Georgetown University 
Nancy Fiedler, PhD - Associate Professor, Department of Environmental and Community 
Medicine, UMDNJ-Robert Wood Johnson Medical School 
Susan Proctor, DSc - Associate Professor, School of Public Health, Boston University; Assistant 
Director, Boston Environmental Hazards Center, Boston VA Medical Center 
2:15 - 3:00	 MCS in Civilian Populations (Panel Discussion) 
Iris Bell, MD, PhD - Staff Physician, Department of Psychiatry, Tucson Veterans Affairs 
Medical Center 
James Cone, MD, MPH - Acting Chief, Occupational Health Branch, California Department of 
Health Services 
Richard Graveling, PhD - Head, Department of Ergonomics, Institute of Occupational 
Medicine, United Kingdom 
William Meggs, MD, PhD - Associate Professor of Emergency Medicine, Vice-Chair for Clinical 
Affairs, Chief, Division of Toxicology, Department of Emergency Medicine, East 
Carolina University School of Medicine 
Anne Solomon, PhD, MA - Research Fellow, Department of Medicine, Pennsylvania State 
College of Medicine 
Roberta White, PhD - Director, Boston Environmental Hazards Center, Boston VA medical 
Center 
3:00 - 3:45	 MCS: The Experience of Patients and Physicians (Panel Discussion) 
Rebecca Bascom, MD, MPH - Professor of Medicine, Pennsylvania State College of Medicine 
Leslie Israel, DO, MPH - Medical Director, UCSF-Stanford Employee and Occupational Health 
Services; Assistant Clinical Professor, Department of Medicine, University of California, 
San Francisco 
Mary Lamielle - Executive Director, National Center for Environmental Health Strategies, Inc. 
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William Rea, MD, FACS - Director, Environmental Health Center-Dallas 
Cynthia Wilson - Executive Director and Chairman of the Board, Chemical Injury Information 
Network and Environmental Access Research Network 
Session IV - Concurrent Workgroup Panels: Review of Major Research Issues 
4:00 - 5:45	 Workgroup 1: Chemical Exposures and Illnesses among Gulf War Veterans: 
Pathophysiology, Etiology, and Mechanisms of Action 
4:00 - 5:45	 Workgroup 2: Assessment/Diagnosis of Illnesses Associated with Chemical
 Exposures 
4:00 - 5:45	 Workgroup 3: Treatment of Gulf War Veterans 
4:00 - 5:45	 Workgroup 4: Prevention 
7:30 - 9:00 Veterans Forum: Open Discussion Regarding Research Priorities 
Facilitator: Michael Sage, MPH - Acting Deputy Director, Division of Environmental Hazards 
and Health Effects, National Center for Environmental Health, Centers for Disease 
Control and Prevention 
Day 2 (Monday, March 1, 1999)
 
Session V: Chemical Exposures: Possible Mechanisms of Action
 
Moderator: Timothy Gerrity, PhD - Special Assistant Chief Research and Development Officer, 
Office of Research and Development, Department of Veterans Affairs 
8:00 - 8:20 Role of Susceptibility 
Hermona Soreq, PhD - Professor of Molecular Biology, Head, Life Sciences Institute, Hebrew 
University 
8:20 - 8:40 Synergistic Effects of Chemical Combinations 
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8:40 - 9:00 The Olfactory System: An Overview 
Richard Doty, PhD - Director, Smell and Taste Center, Professor of Otorhinolaryngalogy, 
University of Pennsylvania Medical Center 
9:00 - 9:20 Toxicant-Induced Loss of Tolerance and Masking 
Claudia Miller, MD, MS - Associate Professor, Department of Family Practice, Environmental 
and Occupational Medicine, University of Texas Health Science Center 
9:20 - 10:00 Panel Discussion
 Mohamed Abou-Donia, PhD; Richard Doty, PhD; Claudia S. Miller, MD, MS; Hermona 
Soreq, PhD 
Session VI:	 Concurrent Workgroup Panels: Opportunity for Public Input Regarding 
Research Recommendations 
10:15 - 12:00 Workgroup 1: Chemical Exposures and Illnesses Among Gulf War Veterans: 
Pathophysiology, Etiology, and Mechanisms of Action 
10:15 - 12:00 Workgroup 2: Assessment/Diagnosis of Illnesses Associated with Chemical
 Exposures 
10:15 - 12:00 Workgroup 3: Treatment of Gulf War Veterans 
10:15 - 12:00 	 Workgroup 4: Prevention 
Session VII: 	 Studying the Health Impact of Chemical Exposures During the Gulf War: 
Methodological Considerations 
Moderator: Stephen Thacker, MD, MSc - Director, Epidemiology Program Office, Centers for 
Disease Control and Prevention 
1:30 - 2:00	 Current Status of Gulf War Exposure Data 
Jack Heller, PhD - Senior Scientist, Deployment Environmental Surveillance Program, United 
States Army Center for Health Promotion and Preventive Medicine 
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2:00 - 3:00 Research Strategies (Panel Discussion) 
Rebecca Bascom, MD, MPH - Professor of Medicine, Pennsylvania State College of Medicine 
John Feussner, MD - Chief Research and Development Officer, Office of Research and 
Development, Department of Veterans Affairs 
Gary Gackstetter, DVM, MPH, PhD - Colonel, United States Air Force, Biomedical Sciences 
Corps; Assistant Professor and Deputy Director, Division of Epidemiology and 
Biostatistics, Department of Preventive Medicine and Biometrics, Uniformed Services 
University of the Health Sciences 
Robert Haley, MD, FACE, FACP - Director, Division of Epidemiology, Department of Internal 
Medicine, University of Texas Southwestern Medical Center 
David Ozonoff, MD, MPH - Chair, Department of Environmental Health, Boston University 
School of Public Health; Medical Director, Boston Environmental Hazards Center, 
Boston VA Medical Center 
Session VIII: Concurrent Workgroup Panels: Finalization of Research Recommendations 
3:15 - 5:30	 Workgroup 1: Chemical Exposures and Illnesses Among Gulf War Veterans: 
Pathophysiology, Etiology, and Mechanisms of Action 
3:15 - 5:30	 Workgroup 2: Assessment/Diagnosis of Illnesses Associated with Chemical
 Exposures 
3:15 - 5:30 Workgroup 3: Treatment of Gulf War Veterans 
3:15 - 5:30 Workgroup 4: Prevention 
Day 3 (Tuesday, March 2, 1999) 
Session IX: Concurrent Workgroup Panels: Finalization of Research Recommendations 
(Continued) 
8:00 - 9:30	 Workgroup 1: Chemical Exposures and Illnesses Among Gulf War Veterans: 
Pathophysiology, Etiology, and Mechanisms of Action 
8:00 - 9:30	 Workgroup 2: Assessment/Diagnosis of Illnesses Associated with Chemical
 Exposures 
8:00 - 9:30 Workgroup 3: Treatment of Gulf War Veterans 
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8:00 - 9:30 Workgroup 4: Prevention 
Sesion X - Research Recommendations 
Moderator: Drue Barrett, PhD - Chief, Veterans’ Health Activity Working Group, National 
Center for Environmental Health, Centers for Disease Control and Prevention 
9:45 - 11:45 Report from Workgroups and Discussion 
11:45 - 12:00 Closing Remarks and Adjournment 
Henry Falk, MD MPH - Director, Division of Environmental Hazards and Health Effects, 
National Center for Environmental Health, Centers for Disease Control and Prevention 
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Appendix E 
Workgroup Members and Facilitators 
Pathophysiology Workgroup: 
Members 
Mohamed Abou-Donia, PhD - Professor, Department of Pharmacology, Duke University 
Medical Center 
David Ashley, PhD - Chief, Air Toxicants Branch, Division of Environmental Health Laboratory 
Sciences, National Center for Environmental Health, Centers for Disease Control and 
Prevention 
Iris Bell, MD, PhD - Staff Physician, Department of Psychiatry, Tucson Veterans Affairs 
Medical Center 
COL Andras L. Korenyi-Both, MD, PhD - United States Army National Guard; Medical 
Director and Director of Clinical Laboratories, Comprehensive Medical Network, 
Pennsylvania 
Claudia Miller, MD, MS - Associate Professor, Department of Family Practice, Environmental 
and Occupational Medicine, University of Texas Health Science Center 
Deborah Norris, PhD - Neurotoxicologist, U.S. Environmental Protection Agency, Office of 
Pollution Prevention and Toxics 
Arnold Peckerman, PhD - Assistant Professor, Department of Neurosciences, University of 
Medicine and Dentistry of New Jersey; Director, Psychophysiology Laboratory. Gulf 
War Research Center, East Orange VA Medical Center 
Satu Somani, PhD - Professor of Pharmacology and Toxicology, Department of Pharmacology, 
Southern Illinois University School of Medicine 
Hermona Soreq, PhD - Professor of Molecular Biology, Head, Life Sciences Institute, Hebrew 
University 
Barbara Sorg, PhD - Assistant Professor, Program in Neuroscience- VCAPP Department, 
Washington State University 
Peter Spencer, PhD - Professor and Director, Center for Research on Occupational and 
Environmental Toxicology, Oregon Health Sciences University 
Barry Wilson, PhD - Professor, Department of Animal Science and Department of 
Environmental Toxicology, University of California, Davis (Workgroup Chair) 
Facilitators 
Sheila Newton, PhD - Director of Policy, Planning, and Evaluation, Office of the Director, 
National Institute of Environmental Health Sciences, National Institutes of Health 
William Suk, PhD - Chief, Chemical Exposures and Molecular Biology Branch, Division of 
Extramural Research and Training, National Institute of Environmental Health Sciences, 
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National Institutes of Health 
Assessment and Diagnosis Workgroup: 
Members 
Maria Rosario Araneta, PhD, MPH - Epidemiologist, Emerging Illness Research Team, Naval 
Health Research Center 
Lawrence A. Bradley, PhD - Professor of Medicine, Division of Clinical Immunology and 
Rheumatology, University of Alabama, Birmingham 
James Cone, MD, MPH - Acting Chief, Occupational Health Branch, California Department of 
Health Services 
Albert Donnay, MHS - Director, MCS Referral and Resources 
Gary Gackstetter, DVM, MPH, PhD - Colonel, United States Air Force, Biomedical Sciences 
Corps; Assistant Professor and Deputy Director, Division of Epidemiology and 
Biostatistics, Department of Preventive Medicine and Biometrics, Uniformed Services 
University of the Health Sciences 
Robert Haley, MD, FACE, FACP - Director, Division of Epidemiology, Department of Internal 
Medicine, University of Texas Southwestern Medical Center 
Howard Kipen, MD, MPH - Associate Professor, Director, Division of Occupational Health 
Environmental and Occupational Health Sciences Institute, UMDNJ-Robert Wood 
Johnson Medical School 
Linda McCauley, PhD - Associate Professor, Oregon Health Sciences University, Center for 
Research on Occupational and Environmental Toxicology 
Karen Schmaling, PhD - Associate Professor of Psychiatry and Behavioral Sciences, University 
of Washington 
Edward Shorter, PhD - Professor, History of Medicine, Faculty of Medicine, University of 
Toronto 
Terry Spittler, PhD - Senior Research Associate, Center for the Environment and Department of 
Food Science and Technology, Cornell University 
Robert Vogt, PhD - Research Chemist, Clinical Biochemistry Branch, Division of Environmental 
Health Laboratory Sciences, National Center for Environmental Health, Centers for 
Disease Control and Prevention 
Roberta White, PhD - Director, Boston Environmental Hazards Center, Boston VA medical 
Center (Workgroup Chair) 
Facilitators 
CDR Patrick McNeilly - Deputy Director, Office of Military Liaison and Veterans Affairs, Office 
of Public Health and Science, Office of the Secretary, Department of Health and Human 
Services 
Moiz Mumtaz, PhD - Science Advisor, Research Implementation Branch, Division of Toxicology, 
86
 
    Research Planning Conference Report 
Agency for Toxic Substances and Disease Registry 
Treatment Workgroup: 
Members 
Rebecca Bascom, MD, MPH - Professor of Medicine, Pennsylvania State College of Medicine 
Stuart Brooks, MD - Professor, Colleges of Medicine and Public Health, Director, Sunshine 
Education and Research Center, Department of Environmental and Occupational Health, 
College of Public Health, University of South Florida 
Daniel Clauw, MD - Associate Professor of Medicine and Orthopaedics, Chief, Division of 
Rheumatology, Immunology, and Allergy, Georgetown University 
Kirstina Dahl, MD - Clinical Instructor, Department of Neurosciences, University of Medicine 
and Dentistry of New Jersey 
LTC Charles Engel, Jr. MD, MPH - Chief, Gulf War Health Center, Walter Reed Army Medical 
Center 
Nancy Fiedler, PhD - Associate Professor, Department of Environmental and Community 
Medicine, UMDNJ-Robert Wood Johnson Medical School 
Victor Gordan, MD - Staff Physician, Outpatient Service, Manchester VA Medical Center 
Leslie Israel, DO, MPH - Medical Director, UCSF-Stanford Employee and Occupational Health 
Services; Assistant Clinical Professor, Department of Medicine, University of California, 
San Francisco 
Mary Lamielle - Executive Director, National Center for Environmental Health Strategies, Inc. 
William Meggs, MD, PhD - Associate Professor of Emergency Medicine, Vice-Chair for Clinical 
Affairs, Chief, Division of Toxicology, Department of Emergency Medicine, East 
Carolina University School of Medicine 
Benjamin Natelson, MD - Professor, Department of Neuroscience, New Jersey Medical School; 
Medical Director, Center for Environmental Hazards Research, East Orange VA 
Medical Center (Workgroup Chair) 
Michael Sharpe, MA, MB, MRCP, MRCPsych - Senior Lecturer in Psychological Medicine, 
University of Edinburgh, Royal Edinburgh Hospital 
Anne Solomon, PhD, MA - Research Fellow, Department of Medicine, Pennsylvania State 
College of Medicine 
Facilitators 
Edwin Kilbourne, MD - Senior Medical Officer, Office of the Director, Division of 
Environmental Hazards and Health Effects, National Center for Environmental Health, 
Centers for Disease Control and Prevention 
Mitchell Wolfe, MD, MPH - Epidemic Intelligence Service (EIS) Officer, Surveillance and 
Programs Branch, Division of Environmental Hazards and Health Effects, Centers for 
Disease Control and Prevention 
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Prevention Workgroup: 
Members 
Henry Anderson, MD - Environmental/Occupational Epidemiologist, Division of Public Health, 
Wisconsin Department of Health and Family Services 
Lt Col Philip Bolton - Medical Advisor, Gulf Veterans Illnesses Unit, Ministry of Defence, 
Whitehall, London 
Larry Edmonds, MSPH - Acting Chief, State Services Branch, Division of Birth Defects and 
Pediatric Genetics, National Center for Environmental Health, Centers For Disease 
Control and Prevention 
Timothy Gerrity, PhD - Special Assistant Chief Research and Development Officer, Office of 
Research and Development, Department of Veterans Affairs 
Jack Heller, PhD - Senior Scientist, Deployment Environmental Surveillance Program, US Army 
Center for Health Promotion and Preventive Medicine 
CAPT Michael Kilpatrick, MD - Director, Medical Outreach and Information, Office of the 
Special Assistant for Gulf War Illnesses 
Max Lum, EdD, MPA - Associate Director for Health Communication, National Institute of 
Occupational Safety and Health 
Melissa McDiarmid, MD, MPH - Assistant Professor of Medicine, University of Maryland; 
Director, VA Depleted Uranium Program, Occupational Health Project, Baltimore VA 
Medical Center (Workgroup Chair) 
James Pirkle, MD, PhD - Assistant Director for Science, Division of Environmental Health 
Laboratory Sciences, National Center for Environmental Health, Centers for Disease 
Control and Prevention 
Douglas Rokke, PhD - Assistant Professor, Department of Physical and Earth Science, 
Jacksonville State University 
COL Ken Scott, MD - Assistant Chief of Staff, Health Support Operational Training Units
 Canadian Forces Medical Group - Headquarters 
LT COL Bob Thompson, Preventive Medicine Action Officer, Logistics Directorate, Medical 
Readiness Division, The Joint Staff 
James Tuite, III, MA - Director, Interdisciplinary Science, Chronic Illness Research Foundation 
Facilitators 
Donna Dean, PhD - Senior Advisor to the Deputy Director, National Institutes of Health 
Timothy Tinker, DrPH, MPH - Chief, Communications and Research Branch, Division of Health 
Education and Promotion, Agency for Toxic Substances and Disease Registry 
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Appendix F 
Summary of Workgroup Members’ Presentations and Highlights of Audience Input 
Pathophysiology Workgroup: 
Workgroup Member Presentations 
Dr. Mohamed Abou-Donia raised three questions that he thought would be important for the 
workgroup to consider: 1) What is the effect of low-level exposures, that is, exposures below a 
threshold level that would cause acute effects? 2) What is causing the delay period between time 
of exposure and onset of clinical signs? 3) What is the prognosis for those who have been exposed 
and who report illnesses? 
Dr. David Ashley emphasized the importance of recognizing and studying the role of genetic 
susceptibility in influencing health outcomes in Gulf War veterans. 
Dr. Iris Bell posited that a substantial subset of Gulf War veterans’ illnesses could be explained by 
chemical sensitization or chemical intolerance. She also suggested avenues for study of factors 
that may render individuals more susceptible to chemical sensitization, including parental genes or 
exposures, earlier stresses in an individual’s life, use of addictive substances, and either peak acute 
chemical exposures or repeated chemical exposures at lower levels. 
COL Andras Korenyi-Both drew the panel’s attention to the role of sand as a common 
denominator. He described his chemical investigations on sand content and his work on Al Eskan 
Disease, involving an immune reaction to the properties of sand located in the central and eastern 
region of the Arabian Peninsula. COL Korenyi-Both suggested that low level chemical warfare 
agents saturated sand particles and entered the blood stream, resulting in a variety of clinical 
symptoms. He recommended studies of sand samples to detect chemical warfare agent 
contamination and studies of the neuromuscular junction by muscle biopsies of symptomatic Gulf 
War veterans to detect signs of low density exposure to cholinesterase-inhibiting chemicals. 
Dr. Claudia Miller discussed a theory of disease involving loss of specific tolerance for previously 
tolerated exposures, including environmental chemicals, foods, and drugs. She described how a 
controlled-exposure hospital unit could be used for studies of people affected with this loss of 
tolerance to determine specific disease mechanisms. 
Dr. Deborah Norris pointed out that assessing human health risk from exposure to a mixture of 
chemicals, as opposed to basing assessments on information for individual chemicals, is important 
to the understanding of illnesses among Gulf War veterans. However, it is a methodology that is 
still developing. Environmental Protection Agency risk assessment and testing guidelines on 
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interactions of chemical exposures can provide some insights toward the development of a 
research program for Gulf War veterans’ illnesses. 
Dr. Arnold Peckerman reported results from his studies on altered immune function in sick versus 
healthy Gulf War veterans, looking at the relationships between self-reported exposure to 
chemicals, post-traumatic stress disorder (PTSD), and levels of cytokines. In his analyses, 
veterans who reported a low level of chemical exposures showed no relationships between their 
PTSD scores and two cytokines (interleukin-2 and tumor necrosis factor-alpha); however, in 
veterans who reported moderate to high levels of chemical exposures, there was a positive 
relationship between the present PTSD scores and those two cytokine levels. These studies 
suggest that Gulf War veterans have altered immune function and that the combination of 
chemical exposure (as self-reported by veterans at this time) and stress levels experienced by 
troops during the war predicts some immune functions currently measurable. 
Dr. Satu Somani is studying neurotoxic effects of interactions of pyridostigmine, sarin, and 
physical exertion. He reported results suggesting that physical stress enhances the delayed effects 
of pyridostigmine in mice, possibly due to oxidative damage from the generation of free radicals. 
Dr. Hermona Soreq described the use of molecular biology to develop rapid, accurate tests for 
exposure and risk assessment and also to help identify those who might be at greatest health risk 
from exposure. She also described gene manipulation studies using transgenic animals in order to 
study the mechanisms of delayed pathology resulting from exposures. 
Dr. Barbara Sorg described studies testing the sensitization hypothesis and developing a rat model 
for multiple chemical sensitivity, using responses to cocaine or amphetamine as a measure of brain 
changes. In her studies, exposing these animals to formaldehyde caused them to show a 
sensitized response to cocaine. 
Dr. Peter Spencer discussed approaches that could be used in order to differentiate and to 
compare the health effects of groups of veterans who had different sets of exposures in the 
various deployment phases of the Gulf War. 
Dr. Barry Wilson described the charge of the workgroup and the importance of the deliberations 
as a “two-way street” between workgroup and audience members.  He suggested a process for 
developing a list of research recommendations which involved focusing on the important 
unfulfilled directions of research. He also emphasized that the best science must drive the effort 
and that the recommendations should be based on testable hypotheses and relevance to veterans. 
Dr. Wilson described several paradigms for conducting research, including population level, 
individual level, organ level, cell level, and molecular level research. He suggested that single 
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Audience Input 
The final research recommendations proposed by the pathophysiology workgroup reflect the 
many comments made by audience members during the workgroup sessions. Some points raised 
by audience members were: 
•	 Include studies of effects of vaccines and physical exposures (such as electric and magnetic 
fields) as well as chemical exposures. 
•	 Make sure of the consistency of case definitions in studies of veterans. 
•	 Exercise care in study design to facilitate the extrapolation of results from animals to humans. 
•	 Include neurological studies of larger groups of veterans. 
•	 Conduct more studies on the synergistic effects of pesticides and other exposures. 
•	 Try to get more veterans under study by using wider recall techniques. 
•	 Look at cellular energetic deficiencies and blocks as a mechanism behind many or all 
symptoms of Gulf War illnesses. 
•	 Do more lymphocyte testing and testing for EEG abnormalities. 
•	 Measure levels of toxic chemicals in various body tissues and fluids before, during, and after 
detoxification in order to verify the chemical etiology of illness. 
•	 Examine pre-morbid indicators of delayed neurological deficits (like Parkinson’s or 
Alzheimer’s diseases), especially interactive factors. 
•	 Disseminate the results of epidemiologic studies more widely. 
•	 Consider the need for a Gulf War library or bibliography. 
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Assessment and Diagnosis Workgroup: 
Workgroup Member Presentations 
Dr. Happy Araneta presented a short discussion of chemically induced adverse reproductive and 
perinatal outcomes. She stressed the importance of the paternal contribution in adverse 
reproductive outcomes since the majority of Gulf War veterans are males. Dr. Araneta described 
the need for proper exposure measurements and identification of confounding variables. 
Dr. Lawrence Bradley discussed the lack of standardization in the methods for assessment and 
diagnosis of chronic fatigue syndrome (CFS), fibromyalgia (FM), and multiple chemical 
sensitivities (MCS). He emphasized the need both for clarity in the criteria used in making 
diagnoses and for the ability to rule out competing sources of variance in research findings. 
Mr. Albert Donnay summarized published information on MCS over the years and the evolution 
into its present day definition. He also submitted to the workgroup a list of criteria that he 
proposed would be useful for defining MCS. 
COL Gary Gackstetter briefly described his early work addressing the health concerns of Gulf 
War veterans. Originally, researchers assumed that an answer should be easy to find; it would just 
involve establishing a tight case definition and quantifying exposures. However, researchers soon 
realized that the problem was much more complex. 
Dr. Robert Haley presented a discussion in support of the theory that the illnesses affecting Gulf 
War veterans are a common-source epidemic and proposed that the study of the illnesses should 
be done in the same manner as studies for other epidemics. Dr. Haley emphasized that a case 
definition needs to be derived and that the next step would be to do a case control study using 
that case definition. He continued with a brief description of the work he is doing with a group of 
Seabees in an effort to develop a case definition. 
Dr. Howard Kipen discussed the problem of observing patients with no physical signs but who are 
sensitive to chemicals. He pointed out that unexplained symptoms are common in the general 
population without identifiable organic cause. These symptoms need a systematic investigation to 
adequately identify an underlying disorder. Dr. Kipen also described the confounding of 
symptoms in patients with psychiatric disorders. 
Dr. Linda McCauley provided background on a case control study involving a case definition that 
consisted of five major areas: musculoskeletal pain, fatigue, cognition problems, gastrointestinal 
complaints, and skin rash. She described how some symptoms (e.g., rashes and gastrointestinal 
complaints) did not appear to affect patients in the study and a revised case definition was derived 
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Dr. Karen Schmaling discussed areas of importance when dealing with CFS patients, including 
precise determination of confounding psychiatric disorders and elimination of interviewer bias. 
Dr. Schmaling also suggested looking at factors that might still be sustaining the illness and 
increase efforts to identify clusters of symptoms using factor analytic techniques. 
Dr. Edward Shorter provided a history of somatization disorders which throughout the years have 
presented in various forms. He emphasized the role of the media and the loss of prestige of the 
medical profession as factors influencing the epidemic spread of illness attribution. 
Dr. Terry Spittler provided some insight on additional avenues leading to information related to 
exposures in Gulf War veterans. He emphasized that reviewing inventories and interviewing 
veterans regarding their practices with environmental hazards might yield additional information 
on exposures. 
Dr. Robert Vogt described his work at the Division of Laboratory Sciences at the National Center 
for Environmental Health looking at populations for new markers. He emphasized the importance 
of examining the role of the immune system in illnesses affecting Gulf War veterans and the need 
for collecting standardized data. He also stressed the importance of conducting case-control 
studies. 
Dr. Roberta White presented comments relating to the experience of war and the overlap of 
variables that produce symptoms in individuals. Such factors include climate and geographic 
conditions, infectious disease, as well as individual factors that may play a role in the overall 
response of people following exposure to chemicals. Dr. White described the charge of the 
workgroup and gave the operative directions for the group. 
Audience Input 
The audience input emphasized the importance of proper diagnosis and assessment of Gulf War 
veterans. Participants strongly pointed to the need for a case definition to correctly diagnose the 
illnesses faced by veterans and separate definable disorders (e.g., PTSD) from undiagnosed 
illnesses in Gulf War veterans. They also expressed concern that efforts need to be expanded in 
the areas of diagnosis and treatment of veterans with undiagnosed illnesses and that it should be 
recognized that although these patients do not present with an easily definable disease, treatment 
may still be necessary. Furthermore, the audience emphasized the importance of physicians and 
other health care workers listening to veterans so that they may properly identify problems and 
determine possible exposures that may have an impact on the patient’s condition. Other members 
of the audience were concerned about the role that multiple chemical sensitivities may play in 
illnesses affecting Gulf War veterans, and specifically about the impact of fragrances. 
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Specific areas that the audience recommended for inclusion in the research agenda included: 
•	 Investigation of the role of autoimmunity in Gulf War illnesses. 
•	 Comparisons of Gulf War veterans with other populations presenting with similar symptoms 
(e.g., Chernobyl liquidators) to identify relationships between exposures and symptoms that 
may provide insight into the problems seen in Gulf War veterans. 
•	 Studies of the role of depleted uranium in the illnesses faced by veterans. 
•	 Investigations into the cause of deaths of Gulf War veterans (e.g., studies done at autopsy) to 
assess physiologic and morphologic changes that may result from exposures during the 
conflict. 
Treatment Workgroup: 
Workgroup Member Presentations 
Dr. Rebecca Bascom discussed the importance of including in treatment research an assessment of 
issues of importance to the patient, such as the patient’s view of what constitutes an adverse 
health event. Quality of life instruments can serve this purpose and should be used as an outcome 
measure for any proposed treatment trial. 
Dr. Stuart Brooks emphasized that, although research has been unable to identify an etiological 
cause for the unexplained illnesses of Gulf War veterans, there are existing treatment protocols 
that can be evaluated without knowing the specific etiologic factors of the illnesses. Treatment 
protocols such as cognitive therapy, wellness protocols, exercise programs, and others should be 
tested as soon as possible. 
Dr. Dan Clauw suggested that treatment regimens that have been used successfully for FM and 
CFS should be used to treat Gulf War veterans. In treating Gulf War veterans, clinicians must 
pay attention to the physiology of the illness(es) and the consequences of illness. Examples of 
consequences of illness include de-conditioning, loss of function, and mood disorders. Dr. Clauw 
suggested that initial low doses followed by gradually increased doses of medications, such as 
tricyclic anti-depressants and beta blockers, may be effective in reducing Gulf War veterans 
symptoms, which will then make adherence to cognitive-behavioral treatments more likely. 
Dr. Kristina Dahl discussed research on the role of cardiovascular dysregulation and war time 
stress in illnesses among Gulf War veterans. The research suggests that Gulf War veterans with 
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condition which could have metabolic consequences consistent with fatigue. Cardiovascular 
dysregulation seen in those with chronic fatigue is worsened by PTSD. Dr. Dahl suggested that 
these effects are surprising as previous research has found that PTSD is associated with an 
autonomic over-reactivity. The fact that cardiovascular hypo-reactivity was correlated with poor 
clinical status suggests that treating cardiovascular hypo-reactivity may result in clinical 
improvement. The orthostatic hypotension seen in the patients with chronic fatigue and PTSD 
suggests that treatment with vasoconstrictors and agents that increase blood volume may be 
beneficial. 
LTC Charles Engel recommended that evidence-based treatments that have been applied to other 
populations with physical symptom-based disorders be evaluated to determine their effectiveness 
when used with Gulf War veterans. LTC Engel described the Gulf War treatment program at 
Walter Reed Army Medical Center. The important components of this treatment include 
collaboration among medical disciplines and between the veteran and the health care provider, a 
focus on disability rather than disease, and education of both patient and significant others about 
the patient’s health conditions. The major goals of the treatment are to improve health and 
overall quality of life and diminish distress about symptoms. Three-month data from the Walter 
Reed program indicate modest improvements in quality of life, distress, and symptom reports. 
Dr. Nancy Fiedler discussed the importance of clinical decision-making regarding appropriate 
treatments to offer Gulf War veterans. Clinicians should use a single case research design to 
evaluate the impact of their interventions. Interventions should be multi-modal in nature and 
problem-focused. The strategy should be first to assess what the primary problems are, and then 
to put people in groups according to those primary problems, gear interventions towards those 
problems, and evaluate them. 
Dr. Victor Gordan described his experience in evaluating over 650 Gulf War veterans. He has 
had disappointing results when focusing treatment on relief of individual symptoms. Dr. Gordan 
hypothesized that illness among Gulf War veterans may involve widespread inflammation which 
affects many organ systems. He suggested that treatment which focuses on reducing 
inflammation should be tried. Dr. Gordan also emphasized the importance of spending time with 
and listening to the patient. 
Dr. Leslie Israel discussed clinical management options that are effective with chemically sensitive 
patients. These include non-judgmental supportive treatment; reduction of odors and irritants, 
and importantly, enhancement of the patient’s control over his or her environment; behavioral 
desensitization, which can be done through bio-feedback and other rehabilitation approaches; 
treatment of co-existing illnesses; and pharmacologic treatment for symptomatic relief. Dr. Israel 
also emphasized that training of physicians should begin during residency training and should 
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Ms. Mary Lamielle discussed her work with civilian populations with MCS. She suggested that 
Gulf War veterans might benefit from changing their behavior to reduce or avoid intake of 
tobacco, caffeinated beverages, high-fat foods, and prescription and over-the-counter 
medications. She suggested that research should be conducted to determine the effectiveness of 
minimizing or avoiding exposures using an environmental medical unit and imaging techniques. 
Ms. Lamielle also emphasized the importance of educating individuals with chemical sensitivities 
about government protections (i.e., Department of Housing and Urban Development policies) and 
the need for more research on the social consequences of illness. 
Dr. William Meggs discussed the need for avoidance research to determine the role of low-level 
chemical exposures in chronic conditions. He also referred to hypotheses regarding the role of 
neurogenic inflammation in MCS and suggested that pharmaceutical research should focus on 
development of a Substance P inhibitor. Finally, he suggested that controlled trials should be 
completed to evaluate the effectiveness of detoxification regimens. 
Dr. Natelson reviewed results from his research on exercise treatment for CFS. The study found 
that minor fatigue symptoms were reduced among patients in the exercise group, but fatigue 
remained unchanged. 
Dr. Michael Sharpe described his experience treating CFS in the United Kingdom using a 16 
session cognitive-behavioral treatment approach. He emphasized the importance of treatment 
being multi-modal, addressing not only the patient’s beliefs, fears and concerns, but also their 
mood, their coping skills, and their behavior, particularly avoidant behavior, with the assumption 
that this will influence physiological processes. Dr. Sharpe has found that the maximum 
treatment effect was seen at one year post-treatment. He speculates that the treatment alters the 
way the patient thinks about his or her problem, increases active problem-solving and activity 
levels, and decreases avoidance. Dr. Sharpe acknowledged that using a multi-modal treatment 
approach does not allow for an assessment of whether one component is more effective than other 
components. Another approach is to use a single modal therapy, such as exercise treatment. He 
suggested that this approach is more effective if used on homogenous subgroups of patients who 
have limited comorbidity. Dr. Sharpe concluded that in order for treatment to be effective, it 
needs to be acceptable to the patient and intensive. 
Dr. Anne Solomon described her experience using a desensitization treatment model that focused 
on visual tasks (i.e., art therapy). She suggested that specific types of art and music therapy be 
evaluated for their effectiveness with Gulf War veterans. 
Audience Input 
The audience input emphasized the need for the immediate provision of treatment to Gulf War 
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veterans. Audience members suggested that the focus of further Gulf War related research efforts 
should be place on clinical trials rather than on basic research. Novel or alternative treatment 
approaches that have anecdotal evidence of efficacy were strongly encouraged by audience 
members. The audience also strongly recommended that a veterans’ advisory group oversee the 
research effort and that status reports on the effectiveness of the treatment should be provided to 
the advisory group in a timely fashion. Results of research should be integrated into the overall 
treatment of veterans as soon as possible. Establishment of a central effort to communicate 
information to veterans, physicians, and other researchers was recommended. It was suggested 
that this outreach effort could be accomplished through the Internet. The Website needs to allow 
for feedback through a question and answer feature that can be used to communicate with 
researchers. In addition, clinicians and researchers need to work in collaboration with veterans 
and their spouses/partners and do a better job of assessing what is important to the veterans. 
Specific treatment approaches recommended or discussed by audience members included: 
•	 Treatment that focuses on removing chemical toxins from the body. Examples provided 
included using enzymes, liposomes, or other carrier systems to remove chemicals from the 
body. 
•	 Use of vitamin, mineral, and/or protein supplements. 
•	 A detoxification program of exercise, sauna, and supplements. 
•	 Treatment with calcium channel blockers, Gabitril®, full laboratory work-ups with 
lymphocyte profiles, fungal and viral panels and antibodies to screen for myelin, smooth and 
striated muscle antibodies, and stomach and thyroid antibodies. 
•	 Treatment that focuses on decreasing inflammation and infection rather than altering 
neurotransmitters (e.g., use of Depakote®, Wellbutrin®, and antibiotics) 
•	 The combined use of cognitive enhancers, anxiolytics, sleep medication, anti-depressants, 
beta blockers, and Modafinil®. 
•	 Use of kinesiology and nutrition to treat chemical sensitivities. 
•	 Use of median regulatory acupuncture. 
•	 Use of glucosamine chondroitin, vitamin B1, thiamin, and methadone, for the treatment of 
pain. 
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cognitive symptoms among patients with Alzheimer’s disease. 
• Use of fish oil, lecithin, vitamin E, selenium, and raw oatmeal. 
• Use of hyperbaric oxygenation and plasmapheresis. 
• Use of medications to influence the immune system. 
In addition to being interested in specific treatment recommendations, the audience expressed 
interest in a number of issues relating to diagnosis and assessment. Specifically, audience 
members expressed concern that proper testing of Gulf War veterans was not being done. Many 
audience members were interested in increasing the availability of a variety of imagining 
techniques. They also recommended wider testing for a variety of environmental exposures, 
especially testing for exposure to depleted uranium and mycoplasma infection. In addition, 
assessment of bipolar disorder was recommended, especially when anti-depressant medications 
are used. Specific assessment measures recommended included the Neuropsychological 
Impairment Scale and the Multi-dimensional Pain Inventory. 
Prevention Workgroup: 
Workgroup Member Presentations 
Dr. Henry Anderson highlighted the importance of pre-screening efforts in identifying individuals 
who may be at increased risk for adverse health outcomes in deployments. He emphasized the 
critical need for training and education, both of the individual service member and at the unit 
level. 
LT COL Philip Bolton described the National Health Service in the United Kingdom, especially 
its ability to conduct disease surveillance and to maintain central records. He included an 
overview of the United Kingdom’s experience in the Gulf War and the lessons learned. 
Mr. Larry Edmonds focused on the need to collect standard reproductive and fertility history from 
all personnel entering military service, and added that this information should be updated 
periodically. He also asserted the importance of collecting biological samples and storing blood 
specimens for subsequent use in clarifying medical histories of military personnel. 
Dr. Timothy Gerrity presented an overview of risk assessment/risk management paradigms 
included in the National Science and Technology Council/Presidential Review Directive 5, “A 
National Obligation: Planning for Health Preparedness for and Readjustment of the Military, 
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prevention, intervention, and treatment strategies can be applied, and discussed how these 
principles might be applied in improving health outcomes from deployments. 
Dr. Jack Heller discussed concepts that are important to the development of better methods for 
environmental exposure assessment, particularly for those exposures of long duration at low-
levels. He emphasized the importance of assessing synergistic and antagonistic interactions, and 
correlating these data with those obtainable from general exposure data and troop movement 
data. 
CAPT Michael Kilpatrick discussed the difficulties facing the practicing military physician, 
particularly those problems related to communication of risk and effective prevention strategies. 
Dr. Max Lum emphasized the importance of health education efforts, particularly those to be 
drawn from the experience of federal, state, and county public health officials in the civilian 
sector. He emphasized that risk communication strategies for the deployed service member 
require careful study. 
Dr. McDiarmid reviewed general principles of public health medicine and related how these 
principles would be applicable to the workgroup’s task of identifying fruitful new research 
directions. She presented a framework of control strategies which formed the context for the 
group’s subsequent recommendations. 
Dr. Douglas Rokke discussed procedures for identifying and handling toxic materials in the Gulf 
War theater and the role of mitigation efforts and criteria in limiting extent of exposures. He 
highlighted the need to recognize and select appropriate courses of action against various threats 
in the military arena. 
COL Ken Scott described Canadian experiences, both in pre- and post-deployment surveillance 
activities of service members and in education of care givers. 
LT COL Robert Thompson identified the key facets of the force health protection program, 
which brings a life cycle management approach to dealing with service members from recruitment 
through active duty, to subsequent civilian life. The key roles of health surveillance and ongoing 
health assessments were addressed, both for individual exposures and for unit exposures. 
Mr. James Tuite highlighted elements of occupational safety programs that are suitable for 
military use and are adaptable for both peacetime and wartime environments. Hazard 
communication strategies, training at all levels, accountability for collection of baseline data, and 
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Audience Input 
The audience members emphasized the core importance of analyzing the effectiveness of new or 
updated prevention strategies put in place by the Department of Defense since 1991. They also 
strongly affirmed the central importance of transmitting accurate, timely, and complete 
information to veterans and their physicians. The audience focused on two central questions 
regarding future research efforts: (1) What research should be done? and (2) How is that 
research going to effect change to protect service members in the future? Key areas of concern 
for audience members were: 
•	 Defining levels of risk, both in the short-term and in the long-term. 
•	 Developing effective risk communication strategies. 
•	 Identifying metrics that can measure effectiveness of prevention strategies. 
•	 Creating ways to effectively link the military health sector to the civilian health sector. 
•	 Engineering protective equipment and gear to be used in environments of potential exposures. 
•	 Improving nutritional content of food provided to service members in deployment arenas. 
•	 Standardizing medical surveillance throughout the service member’s life, both military and 
civilian. 
•	 Including input from veterans throughout the process of developing prevention strategies. 
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